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Summary
 -Galactosidases are biotechnologically relevant enzymes with an important
role in the food industry. Their main application is the manufacture of lactose-
free dairy products. They are also used to prevent the formation of crystals
in refrigerated dairy products, to accelerate cheese ripening and as a tool
for the treatment of whey generated in cheese industries (Adam et al., 2004;
Husain, 2010). The retaining catalytic mechanism of these enzymes yields a
covalent intermediate between the enzyme and the galactosyl group of the
substrate. During hydrolysis this galactosyl group is transferred to a water
molecule, but lactose can also act as acceptor (transglycosylation), yielding a
galactooligosaccharide (GOS). When lactose acts as acceptor of the galactosyl
group the enzyme catalyzes the synthesis of galactooligosaccharides (GOS)
(Davies et al., 1997). This process is named transglycosylation. Therefore, these
enzymes can be used for the synthesis of GOS, with known prebiotic properties.
Some of the benefits of GOS ingesta are improving intestinal microbiota
(Vulevic et al., 2008), anti-adhesive e↵ect against pathogenic microorganisms in
the intestinal tract (Shoaf et al., 2006; Quintero et al., 2011), as well as increased
calcium absorption (van den Heuvel et al., 2000; Whisner et al., 2013). Enzymes
used in the industry for GOS synthesis are obtained from microorganisms such
as Kluyveromyces lactis and Aspergillus oryzae, producing  -(1,6) GOS type,
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whereas those from Bifidobacterium bifidum and Bacillus circulans are used
for  -(1,3) and  -(1,4) GOS production respectively (Rodriguez-Colinas et al.,
2011). Some of the  -galactosidases employed in industry (from Kluyveromyces
lactis, Bacillus circulans and Bifidobacterium bifidum) belong to the GH2
family, according to CAZy classification based on sequence similarity (Lombard
et al., 2014).
Lactose is poorly soluble in water at room temperature (Ga¨nzle, 2012)
but its solubility increases with temperature. Therefore there is interest in
characterizing thermostable  -galactosidases. The use of high temperatures in
industrial processes, allowed by these type of enzymes, also reduces the risks
of contamination by mesophilic organisms.
Immobilization of enzymes provides certain advantages, facilitating their re-
utilization and yielding a product free of enzyme (without additive). Moreover,
in some cases, immobilization stabilizes enzymes against external agents such
as temperature, pH or the presence of proteases, and can even improve their
kinetic properties (Torres-Salas et al., 2011).
In the present study we used the  -galactosidase of hyperthermophilic
bacteria Thermotoga maritima (TmLac) classified in the GH2 family, as study
material, the results obtained for each of the specific objectives raised are
summarized below:
Immobilization of TmLac to facilitate its use in
industrial processes
In this study we have used two di↵erent immobilization methodologies.
On one hand, covalent immobilization was performed on polyvinyl alcohol
magnetic beads activated with epoxy groups. On the other hand non-covalent
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immobilization based on tagging with carbohydrate binding domains (CBMs)
was tested. CBMs facilitate the substrate recognition (usually polysaccharides)
by glycosyl hydrolases (Boraston et al., 2004). Immobilization of TmLac using
CBMs from four di↵erent families (CBM2, CBM5, CBM9 and CBM19) also
aims to characterize the binding specificity of these domains to two of the
most abundant polysaccharides in nature, cellulose and chitin. CBM5 and
CBM2 were obtained from Pyrococcus furiosus chitinase A and B, respectively.
CBM9 was obtained from Thermotoga maritima xylanase A and CBM19
from Saccharomyces cerevisiae chitinase Cts1. Parameters such as support
binding feasibility, enzyme activity of the bound enzyme and recyclability were
analyzed for both types of immobilization. For CBM mediated immobilization
the reversibility and the specificity of interaction has also been studied.
Covalent immobilization e ciency was 20 mg per g of support. Activity
assays showed an increase of the total activity of the bound enzyme compared
with the free version, using both the chromogenic p-nitrophenyl- -D-galacto
pyranoside (pNP- -Gal) or lactose at di↵erent concentrations as substrate.
Furthermore immobilization increased enzyme stability at low temperatures.
This could be explained by an increased rigidity of the enzyme by multipoint
covalent attachment to the support, favoring a more stable conformation
(Mateo et al., 2000; Cowan and Fernandez-Lafuente, 2011).
During analysis of TmLac hybrids with di↵erent CBMs, TmLac CBM5
and Tmlac CBM19 were discarded, since the former displayed only unspecific
binding whereas the latter lost thermostability. Hybrids with CBM9 and CBM2
were bound specifically to cellulose at both pH 6.5 and pH 8.5 and, with
higher e ciency (about two fold) at the more acidic pH (8 mg enzyme per
g of support). CBM2 hybrid also bound e ciently chitin at pH 8.5 (8 mg of
enzyme per g of support). However TmLac CBM9 binding was unstable in
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the presence of glucose and galactose, both hydrolysis products of lactose, and
therefore the hybrid TmLac CBM2 was finally selected.
Hydrolysis of 5% lactose, concentration equivalent that found in milk,
was analyzed. The covalently immobilized enzyme could be reused 4 times,
achieving a complete hydrolysis after each incubation period (3 hours) at
75oC. In the case of the immobilized enzyme tagged with CBM2, the activity
decreased up to 30% after the first cycle of incubation (3.5 hours) at 75oC.
This drop in activity may be explained by the release of the hybrid from the
support or the progressive loss of enzyme activity.
Analysis of the structural determinants of
transglycosylation
In collaboration with Dr. Julia Sanz Aparicio (IFQR-CSIC, Madrid) we
are trying to solve the three-dimensional structure of the protein by X-ray
crystallography. Results obtained so far at low resolution (3 A˚) have revealed
that the quaternary structure of TmLac is an octamer.
Transglycosylation experiments with lactose at a high concentration (25%)
determined that TmLac synthesizes  -3’-galactosyl-lactose and  -6’-galactosyl-
lactose in a 3:1 molar ratio. Based on these results putative key residues for
transglycosylation were analyzed. For this, a structural model of the enzyme
was developed using as template the solved structure of  -galactosidase (LacZ)
from E. coli (Juers et al., 2012). Using Autodock4 a molecular docking of the
major synthesized GOS was carried out, assuming that the structure of this
complex would be similar to the reaction intermediate in the transglycosylation
reaction. Based on this study 12 mutations were designed at 6 di↵erent positions
(V93, V94, W959, D568, F571 and N574) to determine the role of these residues
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in the transglycosylation process.
Mutant analysis suggested that W959 is critical for the synthesis of  -
3’-galactosyl-lactose. The W959A and W959C mutants showed a reduction
of 80% in the synthesis of the trisaccharide. The results suggest that this
residue may be a binding platform of the lactose acting as acceptor of the
galactosyl group, through ⇡-C-H interactions. On the other hand, N574S,
N574A substitutions increased the synthesis of  -3’-galactosyl-lactose between
30 and 40% while  -6’-galactosyl-lactose synthesis was not a↵ected. This e↵ect
could be attributed to the disruption of a putative hydrogen bond between
the residue N574 and the galactosyl moiety to be transferred, giving a more
flexible conformation that would facilitate the transglycosylation process . The
F571L mutation specifically increased  -3’-galactosyl-lactose synthesis up to
40%. This mutation could favour the rotation of the W959 residue to a more
favorable position for the transglycosylation reaction, by the release of steric
impediments. The combinations of mutations N574S/F571L and N574A/F571L
increased two-fold the synthesis of  -3’-galactosyl-lactose specifically.
Phylogenetic analysis of GH2  -glycosidases
Most of  -galactosidases used in industry belong to the family GH2. All
of them have in common the catalytic domain GH2C, but show a great
variability in the presence and arrangement of other non-catalytic domains.
To understand the di↵erent domain architectures (DAs) present in the family
2, their phylogenetic relationships and possible connections between structure
and function, di↵erent bioinformatic methodologies have been applied.
From the proteins classified in family GH2 in CAZy database, only those
that contained the canonical catalytic domain (GH2C) defined in Pfam, were
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selected. All these sequences contain two  -sandwich domains at the N-terminal
end identified as GH2N and GH2. This composition was described by Juers
et al., (1999) as a characteristic feature of the family GH2. Analyzing the
variable C-terminal end of these proteins, 5 DA types were distinguished. One
of the most represented corresponds to the GH2N+GH2+GH2C composition
(Type 1), without any additional domain, which includes proteins classified
as glucuronidases. A variant of this DA (Type 2) consists of a large subunit
(LacL), homologous to DA type 1, and a small subunit (LacM) labeled as
Bgal Small N in Pfam. The active enzyme is the result of the interaction of
LacL/LacM subunits. The most common DA is the type 3, wherein the domain
GH2C is joined to Bgal Small N through a  -sandwich intermediate domain.
C-terminal ends of type 4 enzymes are not structurally identified, while the
C-terminal region of type 5 has a large variability of domains identified (BIG1,
F5/F8, BIG4, etc.) connected to GH2C through a common  -sandwich domain.
The  -galactosidases most widely studied and used in industry belong to types
2, 3 and 5.
Phylogenetic analysis with GH2C sequences shows a close relationship
between the evolution of the catalytic domain and the presence of certain C-
terminal domains (specifically, Bgal Small N and BIG1). On the other hand,
the interpretation of the phylogenetic tree allowed us to propose an evolutionary
model for the enzymes of the GH2 family. One of the most significant results
obtained from this analysis is that the type 2  -galactosidases (composed of
two types of subunits) would be the result of a gene disruption of type 3 after
which the beta  -sandwich, acting as a hinge between GH2C and Bgal Small N
would be lost. This study also shows that although some type 4 proteins, with
uncharacterized C-terminal ends, appear close to type 1, 3 or 5, others have
GH2C sequences unrelated to any of the enzymes characterized so far. The
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structural and functional characterization of this group could provide novel
useful enzymes for industry.
IX

Resumen
Las  -galactosidasas son enzimas biotecnolo´gicamente relevantes por su
papel en la industria de alimentos. Su principal aplicacio´n es la fabricacio´n de
productos la´cteos sin lactosa. Se utilizan adema´s para prevenir la formacio´n de
cristales en productos refrigerados derivados de la leche, acelerar la maduracio´n
del queso y como herramienta para tratar el suero generado en las industrias
queseras (Adam et al., 2004; Husain, 2010). En el mecanismo catal´ıtico
de retencio´n de estas enzimas se forma un intermediario covalente entre la
enzima y un grupo galactosilo proviniente del sustrato. En la hidro´lisis este
grupo galactosilo es transferido a una mole´cula de agua, pero la lactosa
puede actuar tambie´n como aceptor (transglicosilacio´n), sintetiza´ndose un
galactooligosaca´rido (GOS) (Davies et al., 1997). Estas enzimas pueden ser
utilizadas para la s´ıntesis de GOS, cuyas propiedades prebio´ticas son conocidas.
Algunos de los efectos beneficiosos de los GOS son la mejora de la microbiota
intestinal (Vulevic et al., 2008), efectos antiadhesivos frente a microorganismos
pato´genos en el tracto intestinal (Shoaf et al., 2006; Quintero et al., 2011),
as´ı como el incremento en la absorcio´n de calcio (van den Heuvel et al.,
2000; Whisner et al., 2013). Las enzimas utilizadas en la s´ıntesis de GOS a
nivel industrial se obtienen de microorganismos como Kluyveromyces lactis
y Aspergillus oryzae que producen GOS del tipo  -(1,6) mientras que las
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de Bifidobacterium bifidum y Bacillus circulans producen GOS  -(1,3) y  -
(1,4) respectivamente (Rodriguez-Colinas et al., 2011). Algunas de las  -
galactosidasas empleadas en la industria (de Kluyveromyces lactis, Bacillus
circulans y Bifidobacterium bifidum) pertenecen a la familia GH2, segu´n la
clasificacio´n del CAZy (Lombard et al., 2014) basada en similitud de secuencia.
La lactosa es poco soluble en agua a temperatura ambiente (Ga¨nzle, 2012)
pero su solubilidad aumenta con la temperatura. Es por ello que hay intere´s en
caracterizar  -galactosidasas termoestables. El uso en la industria de procesos
a alta temperatura, permitidos por este tipo de enzimas, reduce adema´s los
riesgos de contaminacio´n por meso´filos.
La inmovilizacio´n de enzimas aporta ciertas ventajas, por ejemplo facilitando
su reutilizacio´n y dando lugar a un producto libre de la misma (sin aditivo).
Adema´s, en ocasiones la inmovilizacio´n estabiliza la enzima frente a agentes
externos como la temperatura, el pH o la presencia de proteasas, e incluso
puede mejorar sus propiedades cine´ticas (Torres-Salas et al., 2011).
En el presente estudio se ha utilizado la  -galactosidasa de la bacteria
hipertermo´fila Thermotoga maritima (TmLac) clasificada en la familia GH2
como material de estudio. Los resultados obtenidos para cada uno de los
objetivos planteados se muestran a continuacio´n:
Inmovilizacio´n de la TmLac para facilitar su uso en
procesos industriales
En este estudio hemos empleado dos metodolog´ıas de inmovilizacio´n distin-
tas. Por un lado, inmovilizacio´n covalente sobre esferas magne´ticas de polyvinil-
alcohol activadas con grupos epoxy, y por otro inmovilizacio´n no covalente
basada en el etiquetado con dominios de unio´n a carbohidratos (CBMs). Los
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CBMs facilitan el reconocimiento del sustrato (normalmente polisaca´ridos) por
parte de las glico´sido hidrolasas (Boraston et al., 2004). La inmovilizacio´n de
TmLac usando CBMs de cuatro familias distintas (CBM2, CBM5, CBM9 y
CBM19) tiene adema´s el objetivo de caracterizar la especificidad de unio´n de
estos dominios a dos de los polisaca´ridos ma´s abundantes en la naturaleza, la
celulosa y la quitina. CBM5 y CBM2 se obtuvieron de las quitinasas A y B
de Pyrococcus furiosus, respectivamente. CBM9 proviene de la xilanasa A de
Thermotoga maritima y CBM19 de la quitinasa Cts1 de Saccharomyces cerevi-
siae. Para los dos tipos de inmovilizacio´n estudiados se han analizado distintos
para´metros como son la capacidad de unio´n al soporte, la actividad de la enzi-
ma unida y su reciclabilidad. En el caso de la inmovilizacio´n por CBMs se ha
estudiado tambie´n la reversibilidad y la especificidad de la interaccio´n.
La eficiencia de la inmovilizacio´n covalente fue de 20 mg por g de soporte. Los
ana´lisis de actividad mostraron un incremento de la actividad total de la enzima
unida respecto a la libre, usando tanto el sustrato cromoge´nico p-nitrofenil-
 -D-galacto-pirano´sido (pNP- -Gal) como lactosa a distintas concentraciones.
Adema´s la inmovilizacio´n incremento´ la estabilidad a bajas temperaturas. Esto
podr´ıa explicarse por una mayor rigidez de la enzima al establecer enlaces
covalentes con el soporte en distintos puntos de la estructura favoreciendo una
conformacio´n ma´s estable (Mateo et al., 2000; Cowan and Fernandez-Lafuente,
2011).
Durante el ana´lisis de los h´ıbridos de TmLac con los distintos CBMs,
TmLac CBM5 y Tmlac CBM19 se descartaron dado que el primero mostro´
solo unio´n inespec´ıfica mientras que el segundo perdio´ la termoestabilidad. Los
h´ıbridos con CBM9 y CBM2 se unieron de forma espec´ıfica a celulosa tanto a
pH 6.5 como a pH 8.5, aunque con mayor eficiencia (alrededor del doble) al pH
ma´s a´cido (8 mg de enzima por gramo de soporte). En el h´ıbrido con CBM2
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tambie´n se unio´ de forma eficiente a quitina a pH 8.5 (8 mg de enzima por
g de soporte). No obstante la unio´n de TmLac CBM9 se mostro´ inestable en
presencia de glucosa y galactosa, productos de hidro´lisis de la lactosa, por lo
que finalmente se selecciono´ el h´ıbrido TmLac CBM2.
Se analizo´ la hidro´lisis de lactosa al 5%, concentracio´n equivalente a la
de la leche. La enzima inmovilizada de forma covalente se pudo reutilizar 4
veces, consiguie´ndose una hidro´lisis completa tras cada periodo de incubacio´n
(3 horas) a 75oC. En el caso de la enzima inmovilizada a trave´s de CBM2, la
actividad disminuyo´ un 30% tras el primer ciclo de incubacio´n (3.5 horas) a
75oC . Esta ca´ıda de actividad podr´ıa deberese a la liberacio´n del soporte o la
pe´rdida progresiva de actividad del h´ıbrido.
La inmovilizacio´n covalente es irreversible pero requiere la purificacio´n previa
de la enzima, mientras que la inmovilizacio´n a trave´s de CBMs aporta la ventaja
de la especificidad de la interaccio´n, que puede permitir acoplar purificacio´n e
inmovilizacio´n en un solo paso. Adema´s el soporte en este u´ltimo caso es ma´s
econo´mico que una resina activada.
Ana´lisis de los determinantes estructurales de la
transglicosilacio´n
En colaboracio´n con la Dra. Julia Sanz Aparicio (IFQR-CSIC, Madrid) se
esta´ intentando resolver la estructura tridimensional de la prote´ına mediante
cristalograf´ıa de difraccio´n de rayos X. Los resultados a baja resolucio´n (3 A˚)
obtenidos hasta el momento han desvelado que la estructura cuaternaria de la
TmLac es octame´rica.
Los experimentos de transglicosilacio´n con lactosa a elevada concentracio´n
(25%) determinaron que la TmLac sintetiza  -3’-galactosil-lactosa y  -6’-
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galactosyl lactosa con una relacio´n molar 3:1. En base a estos resultados se
analizo´ que´ residuos podr´ıan ser claves para el proceso de transglicosilacio´n.
Para ello, se construyo´ un modelo estructural de la enzima tomando como
molde la estructura resuelta de la  -galactosidasa (LacZ) de E. coli (Juers et al.,
2012). Mediante Autodock4 se realizo´ un acoplamiento molecular (docking) del
GOS sintetizado de forma mayoritaria, asumiendo que la disposicio´n de dicha
mole´cula en el centro activo ser´ıa similar al intermediario de reaccio´n en el
proceso de transglicosilacio´n. En base a este estudio se disen˜aron 12 mutaciones
en 6 posiciones distintas (V93, V94, W959, D568, F571 y N574), para averiguar
el papel de estos residuos en el proceso de transglicosilacio´n.
El ana´lisis de los mutantes sugirio´ que el residuo W959 es cr´ıtico tanto para la
hidro´lisis como para la s´ıntesis de  -3’galactosil-lactosa. Los mutantes W959A
y W959C mostraron una reduccio´n del 80% en la s´ıntesis del trisaca´rido. Los
resultados sugieren la participacio´n de este residuo como plataforma de unio´n
a la lactosa aceptora del grupo galactosilo mediante interacciones de tipo ⇡-C-
H. Por otro lado, las mutaciones N574S, N574A incrementaron la s´ıntesis del
 -3’-galactosil-lactosa entre un 30 y un 40%, mientras que la s´ıntesis de  -6’-
galactosil-lactosa no quedo´ afectada. Este efecto podr´ıa atribuirse a la ruptura
de un potencial puente de hidro´geno entre el residuo N574 y el grupo galactosilo
que ha de transferirse, dando una conformacio´n ma´s flexible que facilitar´ıa el
proceso de transglicosilacio´n. La mutacio´n F571L incremento´ espec´ıficamente
la s´ıntesis de  -3’-galactosil-lactosa en un 40%. Esta mutacio´n podr´ıa favorecer
la rotacio´n del W959 a una posicio´n ma´s favorable para la transglicosilacio´n,
por la supresio´n de impedimentos este´ricos. La combinacio´n de mutaciones
N574S/F571L y N574A/F571L duplico´ espec´ıficamente la produccio´n de  -3’-
galactosil-lactosa.
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Ana´lisis filogene´tico de las  -glicosidasas de la familia
GH2
La mayor´ıa de las  -galactosidasas utilizadas en la industria pertenecen
a la familia GH2. Todas ellas tienen en comu´n el dominio catal´ıtico GH2C,
pero muestran una gran variabilidad en cuanto a la presencia y disposicio´n
de otros dominios no catal´ıticos. Para entender las diferentes arquitecturas de
dominios (DAs) presentes en la familia 2, as´ı como sus relaciones filogene´ticas y
posibles conexiones estructura-funcio´n, se han aplicado distintas metodolog´ıas
bioinforma´ticas.
De las prote´ınas clasificadas en la familia GH2 en la base de datos
CAZy se seleccionaron aquellas que contienen el dominio catal´ıtico cano´nico
(GH2C) definido en la base de datos Pfam. Todas las secuencias seleccionadas
contienen dos dominios de tipo  -sandwich en posicio´n N-terminal identificados
como GH2N y GH2, composicio´n descrita por Juers et al., (1999) como
caracter´ıstica de la familia GH2. Analizando la parte variable C-terminal de
estas prote´ınas distinguimos 5 tipos de arquitecturas de dominios. Uno de
los ma´s representados se corresponde con la composicio´n GH2N+GH2+GH2C
(Tipo 1), sin ningu´n otro dominio adicional, que incluye prote´ınas catalogadas
como glucuronidasas. Una variante de esta DA (Tipo 2) esta´ formada por
una subunidad grande (LacL), homo´loga a la DA de tipo 1, y una subunidad
pequen˜a (LacM) etiquetada como Bgal Small N en Pfam. La enzima activa
es el resultado de la interaccio´n de las subunidades LacL/LacM. La DA
ma´s frecuente es la de tipo 3, en la que el dominio GH2C esta´ unido al
dominio Bgal Small N a trave´s de un dominio intermedio  -sandwich. Las
enzimas de tipo 4 tienen extremos C-terminal que no esta´n identificados
estructuralmente, mientras que la regio´n C-terminal de las de tipo 5 presenta
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Resumen
una gran variabilidad de dominios identificados (BIG1, F5/F8, BIG4, etc.)
conectados al GH2C a trave´s de un dominio  -sandwich comu´n. Las  -
galactosidasas ma´s ampliamente estudiadas y utilizadas a nivel industrial
pertenecen a los tipos 2, 3 y 5.
El ana´lisis filogene´tico realizado con las secuencias GH2C muestra una
estrecha relacio´n entre la evolucio´n del dominio catal´ıtico y la presencia de
determinados dominios en C-terminal (en concreto, Bgal Small N y BIG1). Por
otro lado, la interpretacio´n del a´rbol filogene´tico nos ha permitido proponer un
modelo evolutivo para las enzimas de la familia GH2. Uno de los resultados
ma´s significativos obtenidos a partir de este ana´lisis es que las  -galactosidasas
de tipo 2 (compuestas por dos tipos de subunidades), ser´ıan el resultado de
una disrupcio´n ge´nica de las de tipo 3 tras la cual se habr´ıa perdido el dominio
 -sandwich que actu´a como bisagra entre GH2C y Bgal Small N. Este estudio
tambie´n muestra que aunque algunas prote´ınas de tipo 4, con extremos C-
terminal no caracterizados, aparecen pro´ximas a las de tipo 1, 3 o 5, otras
presentan secuencias GH2C no relacionadas con ninguna de las caracterizadas
hasta la fecha. La caracterizacio´n estructural y funcional de este grupo podr´ıa
aportar nuevas enzimas u´tiles para la industria.
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CHAPTER 1. INTRODUCTION
Figure 1.1: Title of the first scientific article where a  -galactosidase was mentioned
(Beijerinck, 1889).
1.1 Role of  -galactosidases in food industry
The enzyme  -galactosidase (lactase) was reported firstly by Beijerinck
at the Department of Microbiology and Enzymology at Delft University in
1889 (Figure 1.1). The enzyme, secreted by yeasts, was able to hydrolyze
lactose into glucose and galactose.  -Galactosidases are widely spread in
microorganisms (bacteria, archea, fungi and yeasts), plants and animals.
Besides their predominant hydrolytic activity,  -galactosidases also catalyze
transglycosylation to synthesize galactooligosaccharides and other derivatives
(Park and Oh, 2010). Currently, microbial  -galactosidases are essential
enzymes for di↵erent food applications related to lactose processing. Two main
applications involving these enzymes are the development of lactose-free milk
products for consumers with intolerance (Adam et al., 2004) and the synthesis
of prebiotic galactooligosaccharides (Ga¨nzle, 2012). Other uses are related to
the improvement of food properties. Lactose hydrolysis increases the sweetness
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of products without extra sugar adition, reducing calories. Moreover lactose
hydrolysis reduce precipitation problems in products such as condensed milk or
ice-cream (Adam et al., 2004; Panesar et al., 2006). Finally,  -galactosidases
can be used for the transformation of lactose from whey generated in cheese
industry. High lactose content is associated with an increased biochemical and
chemical oxygen demand in environment. The hydrolyzed waste may be used
as substrate for other industrial applications such as bioethanol production
(Guimara˜es et al., 2010)
1.2 Lactose intolerance
Lactose is the most abundant sugar in milk (5% w/v) (Rosado 1997; Kunz
et al., 2000), and represents the major carbon source for humans in the earliest
stages of life (Adam et al., 2004). Lactose can not be absorbed directly
in the gut and needs to be hydrolyzed previously by a  -galactosidase. In
mammals this enzyme is the lactase-phlorizin hydrolase (LPH). The enzyme
is a major glycoprotein of the microvillus membrane in the human intestinal
mucosa. It is synthesized as a single chain precursor with a subsequent
intracellular proteolytic processing (Sterchi et al., 1990). During the first
stages of development lactase activity is maximum. After a period between 2
and 12 years two phenotypes are di↵erentiated: lactase non-persistant (LNP),
which can not tolerate lactose ingestion and lactase persistent (LP), which can
consume lactose without problems (Mattar et al., 2012). These phenotypes are
directly related to the expression levels of the LPH gene which is dramatically
reduced in LNP adults (Wang et al., 1998). Lactase activity reduction is the
main cause of lactose maldigestion, and is well distinguished from the congenital
lactose intolerance which is a rare disease caused by an autosomic recesive
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mutation that a↵ects infants since their birth (Mattar et al., 2012).
The mechanism of the variation of lactase expression in adults is not
understood. However, there are some polymorphisms in enhancer regions
upstream of the gene that encodes LPH which are more common among
LP subjects (Mattar et al., 2012). In a lactose tolerant person lactose is
hydrolyzed by the lactase located in the brushes of the gut enterocytes (Figure
1.2 A), and glucose and galactose are absorbed by cells through a sodium
cotransporter. This cation transport creates an osmotic gradient that promotes
the absorption of water molecules, reducing the luminal water. In a LNP
phenotype lactose is not digested and it is accumulated in the colon producing
adverse physiologic e↵ects (Figure 1.2 B). High amounts of lactose in the
colon set an osmotic gradient which yields an influx of water into the lumen,
producing diarrhoea. Moreover, lactose is hydrolyzed by  -galactosidases
from the intestinal microbiota, yielding gases that cause blowing, intestinal
distension, abdominal pain, etc (Lomer et al., 2008; Ingram et al., 2009). The
LP phenotype is very common in north-western Europe and is associated to
herding practices (Figure 1.3). However LNP is the major phenotype in the
world, representing ca. 65% of the global population (Ingram et al., 2009).
1.3 Oligosaccharides and prebiotic properties
Oligosaccharides are low molecular weight carbohydrates with a polymer-
ization degree between 2 and 10 connected through linear or ramified glycoside
linkages (Weijers et al., 2008). These molecules show a vast structural diversity
and have di↵erent biological roles in organisms being crucial for development,
growth and cell function (Raman et al., 2005). In food technology oligosaccha-
rides have been commercialized since the 80s as low calorie bulking agents, but
5
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Figure 1.2: Lactose tolerance and lactose intolerance mechanism. (A) In a LP phenotype,
lactase-phlorizin hydrolase (LPH) in the brush border hydrolyzes lactose (Gal-Glc) into
galactose (Gal) and glucose (Glc), which are rapidly absorbed into the bloodstream taking
luminal water with them. (B) In a LNP phenotype, there are several mechanisms for the
symptoms. Unabsorbed lactose passing through the colon generates a high osmotic load
producing the increase of water into the lumen. Moreover, lactose is fermented by intestinal
microbiota producing gases such as CO2, CH4 or H2. SCFA: short chain fatty acids. Adapted
from: (Lomer et al., 2008).
6
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Figure 1.3: Map of Old World lactose persistence (LP) phenotype frequencies. Dots represent
collection locations. Colours and colour key show the frequencies of the LP phenotype
estimated by surface interpolation. Figure from Itan et al., 2010.
in the last years they have received much interest in food and pharmaceuti-
cal industries because of their prebiotic properties and the increased consumer
interest in healthy products (Patel and Goyal, 2011). They are also used as
jelling agents, antioxidants, humectants and in drug delivery. The concept of
prebiotic was proposed by Gibson and Roberfroid in 1995 as “food ingredients
that are not hydrolyzed by gut enzymes and have a healthy e↵ect stimulat-
ing the growth and/or activity of one or a limited number of bacteria in the
colon” (Gibson and Roberfroid, 1995). In 2007 the concept was redefined by
Robertfroid as “a selectively fermented ingredient that allows specific changes,
both in the composition and/or activity in the gastrointestinal microflora that
confers benefits upon host well-being and health” (Roberfroid, 2007).
To consider a food ingredient as prebiotic the following criteria must be
accomplished:
1. Resistance to gastric acidity, hydrolysis by mammalian enzymes, and
gastrointestinal absortion
7
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2. Fermentation by intestinal microbiota
3. Selective stimulation of growth or activity of microbiota that contribute
to health and well-being
Oligosaccharides with prebiotic properties are listed in Table 1.1. Galac-
tooligosaccharides, considered in this study, fulfill the requirements of Rober-
froid’s definition of a prebiotic. Di↵erent health benefits are associated to the
ingest of such compounds as will be detailed below. Products with prebi-
otic e↵ects, such are galactooligosaccharides (GOS) or fructooligosaccharides
(FOS), are used as ingredients of infant formulae for preventing infections and
to stimulate the immune system. Currently the Directive 2006/141/EC on in-
fant formulae allows the adition of GOS-FOS in ratio 9:1 in a quantity of 0.8
g/100 ml of prepared product (Roberfroid et al., 2010).
1.3.1 Gut microbiota improvement and host health
benefits
Gut microbiota has been identified as a key aspect for health and well-being.
The microbiota of the human gastro-intestinal tract constitutes a complex
ecosystem influenced by di↵erent factors. Non-digestible carbohydrates with
prebiotic e↵ects stimulate the growth of bacterial genera/species characterized
exclusively by saccharolytic fermentation which are likely to be more beneficial
to host than those including proteolytic/putrefactive fermentation. The
products of carbohydrate fermentation include short chain fatty acids (SCFA),
mainly acetate, propionate and butyrate, and other metabolites that act as
electron acceptors and gases like H2, CO2, CH4 and H2S.
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CHAPTER 1. INTRODUCTION
SCFA accumulation causes a drop in pH from ileum to the caecum which
changes microbiota composition, and prevents the overgrowth of pathogenic,
acid-sensitive bacteria, like Enterobacteriaceae and Clostridiaceae genera (Dun-
can et al., 2009; Cherrington et al., 1991). Moreover, SCFA play a role in the
host metabolism of lipids, glucose and cholesterol in various tissues. SCFA
reduce cholesterol plasma concentrations in rodents and humans (den Besten
et al., 2013). Another health-beneficial e↵ect associated to prebiotics is related
to the gut associated lymphoid system which provides an initial defence against
intestinal pathogens. The influence of microbiota on the host immune system
may proceed through SCFA interaction with the immune cells and enthero-
cytes, modifying their activity (Roberfroid et al., 2010) or by direct interaction
with intestinal epithelial cells and dendritic cells (Lebeer et al., 2010). Indeed
ingestion of 5.5 g/day of GOS mixture for 10 weeks increased phagocytosis, nat-
ural killer cell activity and production of anti-inflammatory cytokines, while the
production of pro-inflammatories was reduced (Vulevic et al., 2008).
1.3.2 Anti-adhesive e↵ects
Intestinal tract diseases begin with the recognition by the pathogen, or
its toxins, of a cell surface receptor from gut epithelial cells. The anti-
adhesive strategy relies on the structural similarity between the carbohydrates
of the epithelial cell surface receptors and the prebiotic oligosaccharides
(Sinclair et al., 2009). The use of a GOS mixture reduced significantly the
adherence to epithelial cells of an E.coli entheropathogenic strain (Shoaf et al.,
2006), Cronobacter sakazakii (an oportunistic pathogen implied in meningitis,
necrotizing enterocolitis, and sepsis in neonates) (Quintero et al., 2011) and
Ctx toxin from Vibrio cholerae (Sinclair et al., 2009).
10
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1.3.3 Other benefits
GOS increase Ca2+ absorption in animal models, post-menopausal women
and young girls. A collateral e↵ect of the increment of fermentation is
the hypertrophy of the intestinal mucosa that increases the surface area for
greater mineral di↵usion (van den Heuvel et al., 2000; Whishner et al., 2013).
Another benefit associated to GOS ingesta is the protective e↵ect against the
development of colorectal tumours, preventing the growth of microorganisms
that yield aromatic or heterocyclic amines with carcinogenic e↵ects (Bruno-
Barcena and Azcarate-Peril, 2015). Finally, the use of GOS has been reported
to reduce an inflammatory inter-leukin, suggesting their potential application
to treat inflammatory processes and allergies associated with this interleukin
(Verheijden et al., 2015).
1.4 Oligosaccharide synthesis
Oligosaccharides can be obtained by two major methods, depolymerization
of polysaccharides and synthesis from precursors of lower degree of polymeriza-
tion. Both processes can be carried out either by chemical or enzymatic tech-
nologies (Courtois, 2009). However, chemical synthesis is expensive and reports
low yields and therefore, for large scale production, enzymatic methods are the
most common. Both glycosyl hydrolases (GHs) and glycosyltransferases (GTs)
are used. These enzymes are classified in di↵erent families on CAZy database
based on sequence similarity (Lombard et al., 2014).
Glycosyl hydrolases (EC 3.2.1) are enzymes capable to hydrolyze glycosidic
bonds. They are classified in retaining or inverting depending on whether the
reaction mechanism preserves or not the conformation (↵ or  ) of the anomeric
11
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Figure 1.4: Reaction scheme of retaining glycosyl hydrolases. Adapted from Davies et al.,
1997.
carbon atom. The inverting mechanism occurs in a single step involving
two critical residues: one acts as a general base that deprotonates a water
molecule, which carries out the nucleophile attack on the anomeric carbon
whereas the other one acts as general acid and protonates the leaving sugar. On
the other hand, retaining glycosidases proceed through a double substitution
mechanism. In the first step a nucleophilic residue attacks the anomeric
carbon of the substrate and the leaving group is protonated by an acid/base
catalyst. The result is a covalent intermediate between the enzyme and the
glycosyl donor, which is subsequently released by the nucleophilic attack of a
water molecule activated by the acid/base catalyst (hydrolysis). Alternatively,
a transglycosylation reaction may occur when the covalent intermediate is
released by a second sugar molecule acting as glycosyl acceptor (Figure 1.4)
(Davies et al., 1997).
Other enzymes able to catalyze transglycosylation reaction require activated
donors. This is the case of Leloir glycosyltransferases and phosphorylases (EC
12
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Figure 1.5: Synthesis of oligosaccharides with phosphorylases (right side) and Leloir
glycosyltransferases (left side). Adapted from Weijers et al., 2008.
2.4) (Figure 1.5). The acceptor substrate may be a monosaccharide but also
an heteropolysaccharide, oligosaccharide, nucleic acid or lipid (Lairson et al.,
2008; Weijers et al., 2008). Like glycosidases the mechanism can be inverting
or retaining. Phosphorylases in their reverse reaction catalyze the transfer
from phosphorylated monosaccharides to a carbohydrate acceptor, releasing
the phosphate molecule. GTs classified as Leloir enzymes use glycosyl donors
activated with nucleotide mono- or di- phosphate (CMP, UDP, GDP or GTP),
releasing the nucleoside phosphate (Weijers et al., 2008). Despite the diversity
of products synthesized by this type of glycosyltransferases the requirement of
costly activated substrates, make them less attractive than the enzymes using
nonactivated sugars for industrial production and limit their use to high-added-
value oligosaccharides.
13
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1.5 Biochemical and structural properties of
 -galactosidases
 -Galactosidases are classified by the Enzyme Commission as EC 3.2.1.23/108
and hydrolyze D-galactosyl residues connected through  -glycosidic linkages to
polymers, oligosaccharides or secondary metabolites (Adam et al., 2004; Hu-
sain, 2010). They are distributed in four glycosyl hydrolase families, namely
GH1, GH2, GH35 and GH42 (Lombard et al., 2014). These families use a re-
taining mechanism for hydrolysis and belong to the clan GH-A characterized
by a TIM-barrel domain. Only certain enzymes belonging to families GH1 and
GH2 have lactose as the natural substrate, whereas the rest act on di↵erent
galactose-containing glycosides (Husain, 2010).
Microbial  -galactosidases are preferred for industrial applications due to
high e ciency of enzyme production per biomass unit compared to other
sources. One of the galactosidases most widely used in the industry for lactose
hydrolysis belongs to the GH2 family and is obtained from Kluyveromyces
lactis. Fungal enzymes are useful to treat substrates such as whey since they
have generally an acidic pH optimum range (between 2.5 - 5.4). In contrast,
yeast galactosidases have optimum pHs close to neutral (between 6.0 - 7.0).
Bacterial  -galactosidases are also widely used for lactose hydrolysis because
of their good stability being the acid lactic bacteria one of the major groups of
interest (Husain, 2010).
Due to their retaining mechanism,  -galactosidases yield GOS when lactose
acts as both galactosyl donor and acceptor. The transglycosylation/hydrolysis
ratio depends on the structural conformation of the enzyme active site, but
it is also influenced by other factors such as lactose concentration (Bruins et
14
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al., 2003; Ji et al., 2005), water activity and reaction temperature (Millqvist-
Fureby et al., 1998). Enzyme specificity determines the linkage type ( -(1,2),
 -(1,3),  -(1,4) or  -(1,6)) and the polymerization degree of the synthesized
GOS. The most common products are the trisaccharides  -6’-galactosyl-lactose,
 -3’-galactosyl-lactose and  -4’-galactosyl-lactose. GOS structural di↵erences
have been related to their stability and prebiotic potential (Torres et al., 2010;
Hernandez-Hernandez et al., 2012).
Commercial enzymes for GOS synthesis belong to the GH2 family and are
extracted from Kluyveromyces lactis and Aspergillus oryzae, to obtain  -(1,6)
GOS; Bifidobacterium bifidum, for  -(1,3) GOS and Bacillus circulans, for  -
(1,4) GOS (Rodriguez-Colinas et al., 2011). Since high lactose concentration
increases GOS yield (Ga¨nzle, 2012) the use of high temperatures is desirable for
GOS production to increase the lactose solubility. Moreover working at high
temperature reduces the risk of microbial contamination by mesophiles. There-
fore, a considerable e↵ort has been taken in order to identify thermostable  -
galactosidases. Some examples of thermostable enzymes with tranglyscosylat-
ing capacity are GH1  -galactosidases from Sulfolobus solfactaricus and Pyro-
coccus furiosus, that yield  -(1,3),  -(1,6) and  -(1,4)-galactosyl-lactose; GH2
 -galactosidase from Streptococcus thermophilus that yields  -(1,6)-galactosyl-
lactose and the GH42  -galactosidase from Thermus sp., that yields  -(1,3)-
galactosyl-lactose (Greenberg and Mahoney, 1983; Petzelbauer et al., 2000;
Akiyama et al., 2001; Ji et al., 2005). We have selected the thermostable
 -galactosidase from Thermotoga maritima to characterize the GOS chemical
profile of the wild-type enzyme and to carry out a study of the structural de-
terminants of transglycosylating activity within the active site, which has not
been previously addressed with GH2 enzymes (Section 4.6).
The structure of GH2  -galactosidases includes a TIM-barrel domain that
15
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Figure 1.6: Model for the evolution of the 4/7 superfamily of enzymes. A presumed
prototypical ↵/  barrel enzyme with a long, groove-like active site cleft and an extended
polysaccharide substrate is shown at the top. The addition of a cellulose binding domain
(CBD) to either terminus of the ↵/  barrel could give rise to both endoglycosidases and
exoglycosidases (e.g., families 5 and 10). The generation of an enzyme that hydrolyzes small
substrates might have occurred by either of the routes shown utilizing loops and/or a CBD
to turn the active site from a cleft into a pocket. Adapted from: Juers et al., 1999.
contains the catalytic residues and two  -sandwich domains at the N-terminal
side. Juers et al., 1999 studied the evolutionary relationship between  -
galactosidases and other glycohydrolases. Their work suggested the existence
of a primitive TIM barrel catalytic domain able to hydrolyze polysaccharides,
that after the incorporation of two additional domains in N-terminal position,
restricted hydrolysis capacity to small substrates such disaccharides. The
primitive cleft conformation of the catalytic site changed to a pocket-shape,
more adapted to small substrates (Figure 1.6). Despite this common cassette,
16
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 -galactosidase architecture shows some divergence. Most enzymes, named
hereafter canonical  -galactosidases, contain two relatively well conserved  -
sandwich domains at the C-terminal end of the catalytic module. In some cases
functional  -galactosidases are bicistronic enzymes composed by two subunit
types (LacL and LacM). LacL is homologous to the N-terminal domains and
the TIM-barrel, whereas LacM is homologous to the C-terminal  -sandwich
domain of canonical galactosidases. Interestingly, some  -galactosidases with
high tranglycosylating e ciency such as those from Bacillus circulans and
Bifidobacterium bifidum, show a completely divergent modular arrangement at
the C-terminal end. In this work, we have carried out a bioinformatic analysis
to gain insights into the di↵erent architectures of  -galactosidases and the
phylogenetic relationships among their catalytic domains (Section 4.7).
1.6 Enzyme immobilization
The use of enzymes is a common and old practice in industry for many
di↵erent processes (e.g biomass convertion, textile industry, production of
biodiesel, antibiotic synthesis, etc) (Polaina and MacCabe, 2007). A more
recent application of this methodology is enzyme immobilization, which consists
in fixing the enzyme to a solid surface, or to itself creating nets, by di↵erent
techniques (Husain, 2010; Homaei et al., 2013; Sheldon and van Pelt, 2013).
Immobilized enzymes provide di↵erent advantages over the corresponding
free versions. Immobilization facilitates the separation of the enzyme from
the product mixture, allowing its reutilization and the obtention of enzyme-
free products. It also allows the implementation of enzymes in biosensors
(Ball et al., 2003; Lukacheva et al., 2007; Sezginturk and Dinckaya, 2008;
Ammam and Fransaer, 2010). Moreover, in most cases this strategy stabilizes
17
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Figure 1.7: Di↵erent methods for immobilizing enzymes. Modified from: Sheldon and van
Pelt (2013).
the enzyme against external agents such as temperature, pH or proteases,
increasing its life-time. Immobilization may also modify the kinetic properties
of the enzyme either in a positive or negative way (Torres-Salas et al., 2011).
These changes are explained by structural alterations induced by the interaction
with the support or by changes in the di↵usional properties of the enzyme or
the substrates (Homaei et al., 2013).
A universal immobilization protocol for enzymes is not available. Immo-
bilization e ciency depends on the enzyme structure at di↵erent levels (from
primary to quaternary). In silico studies and structure modelling may be used
to select an immobilization method as the most adequate for a specific enzyme,
but in most cases the best immobilization method for a particular enzyme is
determined empirically (Torres-Salas et al., 2011). Enzyme immobilization
methods are classified in three main groups: covalent or non-covalent surface
binding, physical entrapment and self-aggregation by cross-linking (Figure 1.7)
(Mateo et al., 2007b; Torres-Salas et al., 2011; Sheldon and van Pelt, 2013).
• Surface binding. Immobilization to the surface of solid supports of
di↵erent nature can be performed covalently or not covalently. The
18
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fixation can be done using organic polymers, either synthetic (e.g.
polyvinyl, polystyrene), or natural (e.g. starch, chitosan and cellulose) or
inorganic compounds (e.g. zeolite and silica). Some of these supports are
used to cover the surface of a particle or nano-particle with a magnetic
core (e.g. magnetite). Proteins immobilized to these magnetic particles
can be easily separated by the application of an external magnetic field
(Torres-Salas et al., 2011).
Covalent immobilization has as major advantage the high stability of
the linkage (virtualy irreversible) between the enzyme and the carrier,
preventing the decay of the activity by enzyme releasing from the
support. Moreover, covalent binding may occur simultaneously at
di↵erent points of the same molecule (multipoint attachment) yielding
a more stable structure. Organic and inorganic materials can be
functionalized by di↵erent groups (e.g. amino, carboxyl, epoxide, thiol).
Amino and carboxy activated resins require further chemical activation
(e.g. with glutaraldehyde or carboxidiimide) to react with either amino or
carboxylic groups from proteins. Thiol groups react with cysteine residues
but binding is not stable under reducing conditions and in many instances
cysteines are not accessible at the protein surface. Epoxy resins react with
nucleophilic groups (thiol, amino or phenol). Epoxide activated supports
show certain advantages compared to other agents because they do not
require a previous chemical activation and the target residues, mainly
lysines, are abundant and exposed at the surface of proteins. Chemical
reaction between epoxide and amino group needs a previous adsorption of
the protein to the support, usually by hydrophobic interactions promoted
by the addition of ammonium sulphate at high concentrations. In second
generation epoxy-activated resins, this initial adsorption step is promoted
19
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by a secondary derivatitation of the support that promotes electrostatic,
complexing or disulfide bond interactions (Mateo et al., 2007a). Reactive
lysine residues must be uncharged and therefore highly alkaline conditions
are preferred for binding. However this type of covalent immobilization
is not useful for highly glycosylated proteins because the reactive groups
are not accessible (Torres-Salas et al., 2011). For glycosylated proteins
other immobilization methods have been developed, based on the covalent
bond formation between polyurethane foams and the hydroxyl groups of
carbohydrates (Bakker et al., 2000).
Non-covalent immobilization may be based on specific or unspecific
hydrophobic or electrostatic (ionic or non-ionic) interactions. Supports
such as membranes or microparticles of nitrocellulose or polylysine or,
most recently, carbon nano-tubes have been used for unspecific protein
adhesion (Feng and Ji, 2011). The major advantage of this method is
that the protein is not chemically modified and that binding conditions
are less aggressive than those used for covalent immobilization. However,
this kind of immobilization is less stable. Alternatively, non-covalent
binding may involve bioa nity interactions. In this case the binding
support may be modified by a ligand (e.g. protein A/G, streptavidine or
antibodies) with specific a nity for the protein of interest or a tag fused
to it. The main advantage of this approach is that the target protein may
be purified and immobilized in one single step (Homaei et al., 2013).
• Physical entrapment. It consists in the encapsulation of the enzyme
during polymerization of support. The polymeric matrix can be made
of organic or inorganic polymer matrices, such as polyacrilamide and
silica sol-gel, respectively (Sheldon and van Pelt, 2013). This type of
immobilization is the best way to avoid the negative influence of external
20
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agents, such as proteases, which cannot di↵use into the polymeric matrix
(Homaei et al., 2013).
• Self-aggregation. The method consists in the cross-linking of the
enzyme using a bifunctional agent such as glutaraldehyde that yields
carrier-less macroparticles. The absence of carrier reduces a large portion
of non-catalytic elements in the reaction mixture, allowing better space-
time yields and productivity (Sheldon and van Pelt, 2013). Protein
matrices can be synthetized as cross linked enzyme crystals (CLECs)
or cross-linked enzymes aggregates (CLEAs). Both CLECs and CLEAs
can be encapsulated in order to protect them from external agents,
resulting in a combined immobilization procedure (Torres-Salas et al.,
2011; Sheldon and van Pelt, 2013).
In this work two di↵erent types of surface immobilization have been carried
out: covalent immobilization using epoxy activated magnetite supports and a
non-covalent method based in specific bioa nity interactions (Sections 4.2 and
4.3). In the latter case the enzyme was linked to carbohydrate binding modules
(CBMs), with a nity for polysaccharides, as will be explained in the following
section.
1.7 Generation of hybrid enzymes containing
Carbohydrate Binding Modules (CBMs)
CBMs act in nature as auxiliary domains of enzymes that hydrolyze
polysaccharides, such as cellulose, chitin, starch, glycogen, inulin, pullullan
or xylan (Guille´n et al., 2010). These domains bind polysaccharides and have
three general e↵ects: a proximity e↵ect bringing the catalytic machinery onto
21
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Table 1.2: CBMs classification based on fold (Oliveira et al., 2015).
Fold family Fold CBM families (CAZy classification)
1  -sandwich 2, 3, 4, 6, 9, 11, 15, 16, 17, 20, 21, 22,
25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35,
36, 40, 41, 42, 44, 47, 48, 51, 70
2  -trefoil 13, 42
3 cystein knot 1
4 unique 5, 12
5 OB fold 10
6 hevein fold 18
7 unique (hevein-like
fold)
14
the corresponding substrate, a targeting function to specific regions of the
polysaccharides, and a disruptive e↵ect loosening the structure of tightly packed
polysaccharides (Boraston et al., 2004). In few cases, CBMs are involved in the
adhesion of the enzyme to the cell-wall rather than exerting a specific substrate
binding role (Montanier et al., 2009). The most common structural element of
these domains is a beta-sheet. CBMs are classified in 74 families according to
sequence similarity (CAZy database), which are grouped in seven fold families
(Table 1.2 and Figure 1.8).
Within CBMs ligand binding sites, aromatic residues play a substantial role
interacting with the sugar rings of the polymer by ⇡-C-H stacking contacts.
Based on the orientation of these residues CBMs are classified in three main
groups. CBMs belonging to type A show two or three aromatic residues
exposed, and linearly arranged, at the binding site. They are named surface-
binding CBMs and usually interact with crystalline polysaccharides thanks to
22
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Figure 1.8: CBM structures from the di↵erent CBMs folding types. 1:  -sandwich (PDB:
1GU3); 2:  -trefoil (PDB: 3KMV); 3: Cystein knot (PDB: 4BMF); 4: Unique (PDB: 1ED7);
5: OB fold (PDB: 1E8R); 6: Hevein fold (PDB: 1HEV); 7: Unique (hevein-like fold) (PDB:
1DQC).
the planar architecture of the binding site (Figure 1.9 A). CBMs type B bind
amorphous polysaccharides through a cleft in the module that restricts binding
to free single polysaccharide chains (Figure 1.9 B). Type C or lectin-like CBMs
show a pocket-shaped biding site which imposes a restriction to interact only
with oligosaccharides or polysaccharides ends (mono-, di- or trisaccharides)
(Figure 1.9 C) (Guille´n et al., 2010). Despite these structural features are
suggestive of certain binding properties of the CBMs, modules within the same
type show di↵erent substrate specificities.
CBMs have di↵erent biotechnological applications by means of the construc-
tion of bi-functional proteins with various purposes such as: functionalization of
biomaterials for cell immobilization (Wierzba et al., 1995; Andrade et al., 2010),
bioremediation tools for the elimination of organo-phosphorous molecules or
heavy metals from the environment (Richins et al., 2000; Xu et al., 2002),
23
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Figure 1.9: Classification of CBMs based on the conformation of the ligand binding site.
(A) Type A CBM from Trichoderma reesei cellobiohydrolase I (PDB 1CBH) (Cellulose
was manually docked). (B) Type B CBM from Cellulomonas fimi endo-1,4-glucanase C
(PDB 1GU3) and (C) Type C CBM from Thermotoga maritima xylanase 10A (PDB 1I82).
Carbohydrates are green coloured. The aromatic residues in the binding surfaces are coloured
in orange. Adapted from Guille´n et al., 2010.
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molecular probes to construct a cohesin-dockerin microarray for the study of
cellulosomes (Haimovitz et al., 2008), recombinant protein purification, enzyme
engineering, etc. (Oliveira et al., 2015). One of the uses of CBMs is the attach-
ment of these domains to enzymes for protein immobilization (Myung et al.,
2011). For the current study four CBMs from di↵erent families were selected.
CBM2 from Pyrococcus furiosus chitinase A (ChiA); CBM5 from P. furiosus
chitinase B (ChiB), CBM9 from Thermotoga maritima Xylanase A and CBM19
from Saccharomyces cerevisiae Cts1 chitinase. CBM2 and CBM5 show a type
A surface interaction with slight di↵erences in the spatial arrangement of the
aromatic residues (Nakamura et al., 2008) whereas CBM9 is classified as type
C (Notenboom et al., 2001). So far, none of the CBM19 modules has been
characterized structurally or biochemically. The purpose of this study was
to characterize domains with a nity for cellulose or chitin, the first and the
second most abundant polymers on Earth, which may serve as inexpensive
immobilization supports for proteins tagged with such modules.
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CHAPTER 2. OBJECTIVES
The general objective of this work is the study of a thermostable  -
galactosidase from Thermotoga maritima (TmLac), belonging to glycosyl
hydrolase family 2 (GH2). The specific objectives of the work are:
1. Immobilization of TmLac to facilitate its use in industrial pro-
cesses.
2. Analysis of the structural determinants of the transglycosylat-
ing activity to increase galactooligosaccharide production.
3. Phylogenetic analysis of GH2  -glycosidases.
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CHAPTER 3. MATERIALS AND METHODS
3.1 Microbial strains and culture media
Escherichia coli strains used in this work are listed in Table 3.1. Cultures
were incubated for 16 hours in Luria Bertani broth (0.5% yeast extract, 1%
peptone and 0.5% sodium chloride) at 37oC. For overproduction of heterologous
proteins, E. coli cultures were grown in 2XTY media (1% yeast extract, 1.6%
tryptone and 0.5% sodium chloride) at 37oC before induction with IPTG.
Saccharomyces cerevisiae strain BY4741 (MATa his3 1 leu2 0 met15 0
ura3 0) was grown in YPD media (1% yeast extract, 1% peptone and 2%
glucose) at 30oC during 16 hours. Liquid cultures were grown with orbital
shaking at 200 rpm. Ampiciline and chloramphenicol were added to final
concentration of 100 mg/l and 68 mg/l respectively when required. For solid
medium 2% agar was added.
3.2 DNA manipulation and analysis
3.2.1 Enzymatic treatment of DNA
Treatment with restriction endonucleases, phosphorylation of the 5’-ends
with polynucleotide kinase, and ligation with T4 ligase were performed
following the recommendations described in Green et al. (2012).
3.2.2 DNA gel electrophoresis
Gels for DNA analysis were prepared in TBE bu↵er (89 mM Tris, 89 mM
boric acid and 2 mM EDTA) with agarose at 0.7-1% (w/v) of concentration.
Preparative electrophoresis in order to purify DNA fragments was carried out
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Table 3.1: E.coli strains used in the present work. Origin of the microbial strains are defined
as: (1) commercial, (2) laboratory collection, (3) this work.
Strain Genotype /compositions Origin
XL1-BLUE (Stratagene) recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F proAB
lacIqZ M15Tn10 (Tetr)]
1
ROSETTA2 (Novagen) F’   ompT hsdSB (rB  mB ) gal dcm pRARE2 (CamR) 1
XRA XL1Blue transformed with pRARE2 (CamR) isolated from
ROSETTA2
2
TmLac-X XL1-BLUE transformed with pTmWT 3
TmLac-ROS ROSETTA2 transformed with pTmWT 3
TmLac-XRA XRA transformed with pTmWT 3
TmLac N574A-XRA XRA transformed with pTm N574A 3
TmLac N574S-XRA XRA transformed with pTm N574S 3
TmLac W959F-XRA XRA transformed with pTm W959F 3
TmLac W959C-XRA XRA transformed with pTm W959C 3
TmLac W959A-XRA XRA transformed with pTm W959A 3
TmLac F574L-XRA XRA transformed with pTm F571L 3
TmLac V94Q-XRA XRA transformed with pTm V94Q 3
TmLac V94T-XRA XRA transformed with pTm V94T 3
TmLac V93T-XRA XRA transformed with pTm V93T 3
TmLac F571L/N547S-XRA XRA transformed with pTm F571L/N547S 3
TmLac F571L/N547A-XRA XRA transformed with pTm F571L/N547S 3
TmLac E242A/E243A/E244A-ROS ROSETTA2 transformed with pTm E242A/E243A/E244A 3
TmLac E697A/K698A/K699A-ROS ROSETTA2 transformed with pTm E697A/K698A/K699A 3
TmLac K1029A/E1030A/K1031A-ROS ROSETTA2 transformed with pTm K1029A/E1030A/K1031A 3
TmLac CBM9-ROS ROSETTA2 transformed with pTm CBM9 3
TmLac CBM2-ROS ROSETTA2 transformed with pTm CBM2 3
TmLac CBM5-ROS ROSETTA2 transformed with pTm CBM5 3
TmLac CBM19-ROS ROSETTA2 transformed with pTm CBM19 3
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in TAE bu↵er (40 mM Tris, 20 mM acetic acid and EDTA 1 mM pH 8) with
low melting temperature agarose (0.7-1% (w/v)). DNA fragments were purified
using “QIAquick Gel extraction kit” from Qiagen.
3.2.3 DNA isolation
Plasmidic DNA was purified from 3 ml E. coli cultures. DNA purification
was carried out by the alkaline lysis method (Bimboim and Doly, 1979), for
analytical purposes, or with a commercial kit, for preparative purpose (GeneJet
Plasmid Extraction Kit (Thermo Scientific)).
Yeast genomic DNA was obtained from 4 ml yeast culture using a fast DNA
isolating method (Polaina and Adam, 1991) with modifications introduced in
Latorre-Garcia et al. (2007).
3.2.4 DNA cloning vectors
The vector used for gene cloning and expression was pQE-80L (Qiagen).
This vector contains an ampiciline resistance gene as positive selection factor.
Gene expression is triggered by a hybrid promoter inducible by galactose or
IPTG (isopropil- -D-galactopiranoside). A histidine tag next to the multiple
cloning site (MCS) is fused in frame to the 5’ side of the inserted sequence.
The presence of the lacI repressor ensures tight control at the transcriptional
level of the cloned gene (Figure 3.1).
3.2.5 DNA amplification by PCR
DNA amplification was carried out with Phusion TM polymerase II Hot
Start High-Fidelity DNA Polymerase (Thermoscientific) (3-5 U/µl) or Roche
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Figure 3.1: PQE-80L vector used for the overexpression of T. maritima  -galactosidase gene.
Expand High Fidelity (3 U/µl) according to instructions of the manufacturer.
PCR products were purified with a commercial kit (QIAEX II Gel Extraction
Kit (Qiagen)).
3.2.6 Generation of WT TmLac construct
The  -galactosidase encoding gene from commercial T. maritima was
amplified from genomic DNA (DSM3109) (1 ng/µl) using primers JM771 and
JM772, which contained restriction sites for SacI and PstI to facilitate cloning
into pQE-80L vector (Table 3.2). The primers were designed based on the
TmLac gene sequence published by Moore et al. (1994). The purified PCR
product and vector pQE-80L were digested with restriction enzymes SacI and
PstI at 37oC for 1.5 hours, and purified after electrophoresis. Subsequently, the
vector and the gene were ligated by incubation with T4 DNA ligase at 16oC
overnight. The ligation mixture was used to transform XL1-BLUE strain and
the resulting plasmid was named pTmWT.
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Table 3.2: Primers used in the cloning of  -galactosidasa gene from T. maritima. Restriction
sites are indicated in italics.
Primer Sequence Characteristics
JM771 CACGAGCTCAAGAATATGCCCTACGAATGGG Forward with SacI restric-
tion site
JM772 GTGCTGCAGTCACCTCACGTAGATAGTTTTTCTC Reverse with PstI restric-
tion site
DT889 AGCCGTCGACCCTCACGTAGATAGTTTTTCTCGTG Reverse without stop
codon and SalI restriction
site
Figure 3.2: Constitution of CBM-containing TmLac pQE 80L plasmid.
3.2.7 Construction of TmLac CBM hybrids
To generate TmLac CBM hybrids, the TmLac encoding sequence, excluding
the stop codon, was previously cloned within the SacI/SalI sites of pQE80L,
using primers JM771/DT889 (Table 3.2). Subsequently, DNA sequences en-
coding di↵erent CBMs were amplified from genomic DNA of the corresponding
organism and fused to the C-terminus of the  -galactosidase gene of T. mar-
itima as shown in Figure 3.2. CBM2 and CBM5 from P. furiosus ; CBM19 from
S. cerevisiae and CBM9 from T. maritima were selected. Genomic DNA from
T. maritima (DSM310) and Pyrococcus furiosus (DSM3638) were pucharsed
from DSMZ collection, and DNA from S. cerevisiae BY4741 was isolated as pre-
viously described (Section 3.2.3). Primers used to amplify the di↵erent CBMs
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are listed in Table 3.3. In some cases, a linker of two flexible residues was
inserted between the TmLac and the CBM region. Resulting plasmids were
named pTm CBM9, pTm CBM2, pTm CBM5 and pTm CBM19, accordingly
to the CBM module used in each case.
3.2.8 Site-directed mutagenesis
Site-directed mutagenesis was performed using a modification of the protocol
described by Hemsley et al. (1989). The method consists in the amplification
of the plasmid carrying the target gene using diverging oligonucleotides with
the desired mutation. Subsequent phosphorylation of 5’ ends by polynucleotide
kinase (Thermo Scientific) and final religation with T4 DNA ligase (Thermo
Scientific) were carried out (Figure 3.3). Amplification was performed using a
DNA polymerase with proof reading ativity that produces blunt ends (Phusion
High-Fidelity DNA Polymerase, Thermo Scientific) following manufacturer
instructions with the primers shown in Table 3.4. E. coli XRA strain was
used as the final recipient strain for protein overproduction.
3.2.9 DNA sequencing
The accuracy of gene amplification of TmLac gene, CBMs and all generated
mutants was tested by DNA sequencing carried out by the Central Service
for Experimental Research from Universitat de Vale`ncia, using a 3730 DNA
analyzer (Applied Biosystems).
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Table 3.3: PCR primers used to generate TmLac CBM constructs. Restriction sites are
indicated in italics.
Primer Sequence Comments
DT878 CTATCCGTCGACACGCTTTCCCCAACAACG Forward primer for CBM19 amplifica-
tion introducing SalI restriction site.
DT879 GGACTAAAGCTTTTAAAAGTAATTGCTTTCCAAATAAGAG Reverse complementary primer for
CBM19 amplification introducing
HindIII restriction site.
DT890 ATGAGTCGACGGCGCAGGAATAATGGTAGCGACAGC Forward primer for CBM9 amplifica-
tion introducing SalI restriction site
and Gly + Ala between TmLac and
CBM as linker (underlined).
DT891 GGAGACAAGCTTTCACTTGATGAGCCTGAGGTTAC Reverse complementary primer for
CBM9 amplification introducing
HindIII restriction site.
2DT21 ATGAGTCGACGGCGCAAGCACTTCAATGGAAAACCTAGTC Forward primer for CBM5 amplifica-
tion introducing SalI restriction site
and Gly + Ala between TmLac and
CBM as linker (underlined).
2DT22 GGAGACAAGCTTAGTTGGCTCTGCCTCACCC Reverse complementary primer for
CBM5 amplification introducing
HindIII restriction. site.
2DT23 ATGAGTCGACGGCGCAACAACTACCCCTGTCCCAGTCTC Forward primer for CBM2 amplifica-
tion introducing SalI restriction site
and Gly + Ala between TmLac and
CBM as linker (underlined).
2DT24 GGAGACAAGCTTAATTACTTGTCCGTTTATTTCTAGGGTTATTTC Reverse complementary primer for
CBM2 amplification introducing
HindIII restriction site.
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Figure 3.3: Scheme of site directed mutagenesis protocol. Light blue arrow corresponds
to the  -galactosidase gene. The plasmid to be mutated (pTmWT) was amplified using
two primers which anneal adjacent in opposite directions (purple arrows) one of which was
designed including the mutation of interest (star). The mutant plasmid was recovered after
phosphorylation (red dots) and religation of the amplified fragment (Hemsley et al., 1989).
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Table 3.4: Primers used to generate mutant versions of TmLac. Plasmid pTmWT was used
as template. Underlined sequences correspond to introduced mutations.
Primer Sequence Plasmid
DT931 GTTTATCCATTTGAACCGAACCC pTm V93T
DT930 CGTGTTCGTGTAGATGGGCTTTCC
DT932 ACTTATCCATTTGAACCGAACCCTCC pTm V94T
DT932 CACGTTCGTGTAGATGGGCTTTC
DT933 CAGTATCCATTTGAACCGAACCCTCC pTm V94Q
DT934 CACGTTCGTGTAGATGGGCTTTC
DT927 AGCGGAAACTTCTGTATAAACGGTGTG pTm D568S
DT929 ATTCGGTGTGTCACCGAAGTCAC
DT928 GCCGGAAACTTCTGTATAAACGGTGTG pTm D568A
DT929 ATTCGGTGTGTCACCGAAGTCAC
DT829 TATAAACGGTGTGGTACTGCCCG pTm F571L
DT935 CATAAGTTTCCGTCATTCGGTGTGTC
DT830 TATAAGCGGTGTGGTACTGCCCGATAG pTm N574S
DT831 CAGAAGTTTCCGTCATTCGGTG
DT925 TATAGCCGGTGTGGTACTGCCCGATAG pTm N574A
DT831 CAGAAGTTTCCGTCATTCGGTG
DT942 TATAGACGGTGTGGTACTGCCCGATAG pTm N574D
DT831 CAGAAGTTTCCGTCATTCGGTG
DT859 GCGGGTGCGATGCCTCATCTG pTm W959A
DT834 GCTGTCGTCTCCTCCAAGGC
DT859 GCGGTGCGATGCCTCATCTGG pTm W959C
DT834 GCTGTCGTCTCCTCCAAGGC
DT833 TTGGTGCGATGCCTCATCTGG pTm W959F
DT834 AGCTGTCGTCTCCTCCAAGG
DT830 CATAAGTTTCCGTCATTCGGTGTGTC pTm F571L/N574S
DT935 TATAAGCGGTGTGGTACTGCCCGATAG
DT925 CATAAGTTTCCGTCATTCGGTGTGTC pTm F571L/N574A
DT935 TATAGCCGGTGTGGTACTGCCCGATAG
2DT8 CAGCCAAAGACCTTGAAGTAACACTCATCACC pTm E242A/E243A/E244A
2DT9 CCGCCTCACCGAGATTTCTCATCTCTAC
2DT10 GCCGCATCCATTTCAGATGGAGTGTCACTC pTm E697A/K698A/K699A
2DT11 CGCAAATGCCGGTGCTTTCAGAAG
2DT12 GCCGCACAGGTGGTTCTCTTTGTTGATG pTm K1029A/E1030A/K1031A
2DT13 CGCGCTCAGTGGAGTGTCGTTCAG
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3.3 Gene expression, protein extraction and
purification
Two host strains were used for heterologous gene expression: E. coli
ROSSETA2 and XRA. In preliminar assays ROSSETA2 strain showed better
yields for TmLac production, and this was the choice to overproduce and purify
proteins for crystallization assays. However enzymatic assays of the di↵erent
TmLac mutants were performed directly from total protein extracts. Therefore,
in order to avoid a putative interference of E. coli endogenous  -galactosidase,
the strain XRA ( lac) was selected in these cases.
Transformant bacteria were cultured at 37oC in 2XTY medium with
ampicillin (100 mg/ml) and chloramphenicol (68 mg/ml) until an OD of 0.6
at 600 nm was reached. Gene induction was carried out with IPTG (1 mM
final) for 3 to 5 hours at 37oC or for 16 hours at 16oC, depending on the
optimum conditions for each protein. The cells were collected by centrifugation
at 4000 g for 20 minutes at 4oC and the pellet was concentrated 20-100 fold
in bu↵er A (20 mM phosphate bu↵er, pH 7.4, 10 mM imidazole, 500 mM
NaCl) supplemented with protease inhibitor cocktail (Complete EDTA-free
(Roche)). Highly concentrated cell suspensions used for protein purification
were incubated 30 minutes with lysozyme (1 mg/ml). In all cases, cells were
disrupted by sonication in a B. Braun-BIOTECH LABSONIC with 5 pulses
of 30 seconds at 185 W and a 0.5 frequency, alternating with 30 seconds of
incubation on ice.
Protein extracts were subjected to a heating treatment of 15 minutes at
85oC in order to denature mesophilic proteins. Afterwards, samples were
centrifuged at 15000 g for 20 minutes at 4oC and the supernatant was further
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Figure 3.4: Ni-a nity cromatography steps used for purification of  -galactosidase from
Thermotoga maritima. (1): equilibration, (2) washing unbound proteins, (3) washing of
loosely bound proteins, (4) elution of tightly bound proteins,(5) final column wash, (6) re-
equilibration. X-axis represents column volumes (CV) and Y-axis % of elution bu↵er (%B).
purified using a nickel a nity column (Nickel A nity 5 ml Cartridge Company
ABT). Chromatography conditions are detailed in Figure 3.4. The column
was equilibrated with bu↵er A (10 mM imidazole, 500 mM NaCl and 20
mM phosphate bu↵er, pH 7.4) and elution was carried out with increasing
concentrations of bu↵er B (500 mM imidazole, 500 mM NaCl and 20 mM
phosphate bu↵er pH 7.4). The equipment used for chromatography was an
A˚KTA-Purifier (GE Healthcare). Tmlac CBMs hybrids were purified using the
same conditions described previously, but reducing the column volume to 1 ml
(HisTrap FF crude Healthcare) and without the previous heat treatment step.
Fractions with more than 95% purity (as determined by SDS-PAGE), were
dialyzed in 20 mM Tris-HCl bu↵er pH 7.5 with 50 mM NaCl and concentrated
when required by ultra-filtration with a 20 kDa pore size filter (Pierce).
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Crude protein quantification was carried out by Bradford assay (Bradford,
1976) and purified protein quantification was performed spectrophotometrically
using theoretical extinction coe cients based on sequence composition.
3.4 Protein electrophoresis and western blot
Samples were mixed in a 1:1 proportion with 2X protein loading bu↵er
(125 mM Tris-HCl, 4% SDS, 20% glycerol, 0.05% bromophenol blue and  -
mercaptoethanol) and heated at 95oC for 10 minutes. Electrophoresis on
polyacrylamide gel 10% (100 V 1 hour) was performed as described in Sambrook
et al. 1989, using the OmniPage Mini device (Cleaver Scientific). Gels were
stained with Coomassie blue solution (Coomassie brilliant blue R250 0.25%
(w/v), methanol 50% (v/v)) and 10% acetic acid (v/v). Alternatively, for
western blot analysis, the proteins were transferred to nitrocellulose membranes
(1h, 100V) with a commercial transfer system Mini Trans-BlotR (BioRad)
in TB bu↵er (25 mM Tris, 150 mM glycine and 20% methanol, pH 8.3).
After a blocking treatment with 3% BSA in TBS (10 mM Tris, 150 mM
NaCl pH 7.5) for 30 minutes at room temperature, membranes were incubated
overnight at 4oC with rabbit anti-His antibody (His-probe H-15, Santa Cruz
Biotech) diluted 1:200 in TBS and 3% BSA. After several washes of 10 min
with TBS-T (0.1% Tween 20 in TBS) the membrane was incubated with the
secondary antibody, conjugated with peroxidase (anti-Rabbit IgG HRP, Santa
Cruz Biotech) diluted 1:5000 in TBS with 2.5% milk powder, for 2 hours at
room temperature. After washing with TBS-T the membrane was analysed
with a chemiluminescent substrate (ECL western blotting substrate Pierce,
Thermo Scientific) and the signal was detected with a CCD (Fujifilm LAS-
1000 plus) camera. Image analysis for band quantification was performed using
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Quantity One software (Bio-Rad).
3.5 Protein immobilization
3.5.1 Covalent immobilization of TmLac to magnetic
beads
For covalent enzyme immobilization, magnetic beads with epoxy activated
groups (M-PVA Chemagen E02) were used. The beads, preserved in acetone,
were washed with binding bu↵er (50 mM sodium borate bu↵er, 50 mM KCl
pH 10) and equilibrated twice for 10 minutes with the same bu↵er. After every
wash, the spheres were separated from the liquid using a magnet. The enzyme
(0.25 mg/ml) was incubated with the spheres (1.5 mg/ml) in binding bu↵er
with 2 M (NH4)2SO4 for 4 hours at 37oC with shaking at 180 rpm. Unreacted
epoxy groups were blocked by incubation with 250 mM Tris pH 8 bu↵er for
2 hours with shaking at room temperature. Finally the enzyme loaded beads
were re-suspended in 20 mM Tris, 50 mM NaCl pH 7.5 bu↵er to be preserved
at 4oC until use.
3.5.2 CBM-mediated TmLac immobilization
Non-covalent immobilization was carried out using either chitin or cellulose
as support. These experiments were performed using either a crude cell extract
or purified protein.
Protein crude extract (1 µg/µl) or purified protein (1 µM) was incubated
with 10 mg/ml chitin (Sigma C7170) or acid washed-cellulose (Fluka 22184-
F) in bu↵er 20 mM phosphate pH 6.4 or 20 mM Tris pH 8.5 at 37oC with
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shaking (200 rpm) during 4 hours. Control samples without polysaccharide
were incubated in parallel under the same conditions.
Binding assays with extracts were used to analyze binding specificity of
the TmLac CBM hybrids compared to the rest of E. coli proteins. In this
case, after incubation with the polysaccharide, samples were centrifuged (5
min. 15000 g) and pellets were subjected to sequential washing steps to reduce
the unspecific binding (Figure 3.5). Finally pellets with bound enzyme were
re-suspended in 250 µl of assay bu↵er (50 mM phosphate, 10 mM NaCl, 1
mM MgCl2, pH 6.5) for an SDS-PAGE analysis. When purified protein was
used, samples containing chitin or cellulose were centrifuged after binding
and the  -galactosidase activity of the supernatant (unbound enzyme) and
that of the control samples (total enzyme) was assayed with p-nitrophenyl
 -D-Galactopyranoside (pNP- -Gal). These data were used to calculate the
percentage of bound enzyme to each support (Figure 3.6). In order to study
binding stability, pellets were washed with 800 µl of the corresponding binding
bu↵er (pH 6.5 or 8.5) to remove any excess of unbound protein and were
resuspended and incubated with assay bu↵er (50 mM phosphate, 1 mM MgCl2,
pH 6.5) containing or not a mix 1:1 of glucose and galactose (150 mM each)
during 30 min. at 75oC. After centrifugation the supernatant (including released
enzyme) was collected. The pellet (bound enzyme) was washed with 800 µl of
assay bu↵er and finally resuspended in 250 µl of the same bu↵er. Both released
and bound samples were analyzed by SDS-PAGE (Figure 3.6).
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Figure 3.5: Analysis of binding a nity to cellulose or chitin with protein extracts containing
WT TmLac or TmLac CBM hybrids (B = bound enzyme; C = control).
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Figure 3.6: Analysis of binding a nity and binding stability with purified WT TmLac
and TmLac CBM hybrids. B and R correspond to the bound and released fractions after
treatment of immobilized enzyme at 75oC in di↵erent media. The percentage of binding was
calculated as indicated where AC and ANB are the  -galactosidase activity of the control (C)
and not bound (NB) samples, respectively. B and R correspond to the bound and released
fractions after treatment of immobilized enzyme at 75oC in di↵erent media.
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3.6 Enzyme assays
3.6.1  -galactosidase assays with pNP- -Gal
Enzymes were incubated with 5 mM pNP- -Gal in assay bu↵er (50 mM
phosphate, 10 mM NaCl, 1 mM MgCl2, pH 6.5) at 75oC. The reactions were
stopped by adding 1 ml of 1 M Na2CO3. The activity was spectrophotometri-
cally monitored by measuring the optical density at 400 nm which corresponds
to the maximum absorbance of p-nitrophenyl at basic pH.
3.6.2  -galactosidase assays with lactose
Enzyme preparations were incubated with lactose at di↵erent concentrations
in assay bu↵er (50 mM phosphate, 10 mM NaCl, 1 mM MgCl2, pH 6.5) or milk
at 75oC. The reaction was stopped by heating at 95oC for 10 minutes. The
amount of glucose released was determined using a commercial glucose assay
kit (Glucose (GO) Assay Kit, Sigma). One unit of activity was defined as the
amount of enzyme releasing one µmol of glucose per minute using lactose at
25% (w/v) as substrate.
3.6.3 Measurement of enzyme GOS production
Enzyme preparations (0.7 - 0.8 U/ml) were incubated with lactose at
25% (w/v) in assay bu↵er at 75oC under shaking (200 rpm). The reaction
was stopped by heating at 95oC for 10 minutes. The product profile was
analyzed using anion exchange chromatography equipped with a CarboPac
PA-100 column and an amperometric detector (Dionex, Thermo Scientific).
The program used for each chromatographic separation is shown in Table
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Table 3.5: Program used for the analysis of synthesized GOS by anion exchange cromatogra-
phy in a DIONEX equipment. The solutions used in the mobile phase were: (A) water; (B)
1 M NaOH; (C) 1 M NaOAc and (D) water. Time 0 represents the time of sample injection
and negative times correspond to washing and equilibration steps. Concentration changes
were performed with linear gradients.
Time (min) %A %B %C %D
-35.0 25 30 20 25
-30.1 10 30 50 10
-30.0 45 10 0 45
0.0 45 10 0 45
2.0 45 10 0 45
5.0 35 30 0 35
12.5 27,5 30 15 27,5
12.6 45 10 0 45
3.5. Sugar standards ( -6’-galactosyl-lactose,  -3’-galactosyl-lactose, glucose
and galactose) were analyzed in the same conditions to identify and quantify
reaction products. All samples were clarified before injection through a filter
of 0.45 µm pore size.
3.7 Bioinformatic tools
3.7.1 Analysis of DNA and protein sequences
DNA sequence analysis was carried out with DNAMAN 4.03 (Lynnon
Biosof) and Serial Cloner 2.6.1 (http://serialbasics.free.fr/Softwares.html).
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Protein and DNA sequence alignments were made with Bioedit (Hall, 1999)
using Clustal W algorithm (Larkin et al., 2007). Protein molecular weight
and theoretical extinction coe cient were calculated using ProtParam server
(Walker et al., 2005).
3.7.2 Protein structure modeling and docking
Structure modeling of TmLac was carried using the I-TASSER server (Zhang
2008; Roy et al., 2010 and Zhang et al., 2015). The structure obtained were
analyzed with Pymol Software (Schro¨dinger, LLC, 2010). Docking of  -3’-
galactosyl-lactose and  -4’-galactosyl-lactose in TmLac and Bacillus circulans
(PDB: 4YPJ)  -galactosidase was performed using Autodock sofware (Morris
et al., 2009).  -3’-galactosyl-lactose and  -4’-galactosyl-lactose coordinates
were obtained by Glycam Web Tool (http://glycam.org (Accesed in 2016))
(Kirschner et al., 2008). Using AutodockTools, hydrogens for ligand and
receptor were added and charges were assigned with the t method. All the
hydroxyl bonds and glycosidic bonds were made rotatable, but not the sugar
ring bonds. Autodock 4.0 was executed 100 times using Lamarckian algorithm
(LGA), a population of 150, mutation rate of 0.02 and a rate crossover of 0.8.
Simulations were performed using a maximum of 2500000 energy evaluations
and a maximum of 27000 generations. Results of the docking were grouped
using a cut value of 2.0 A˚.
3.7.3 Analysis of domain architectures
GenBank accesion numbers of protein sequences classified in the GH2 family
were retrieved from the CAZy database (Lombard et al., 2014) and mapped
in the Uniprot database (Consortium, 2015) using the tool “Retrieve/IDmap-
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ping” (http://www.uniprot.org/uploadlists/(Accessed November 2015)). This
operation yielded the UniProt code, GI number and Pfam domains of the dif-
ferent sequences, including the start and end coordinates of the domain limits
(envelope) (Finn et al., 2014). A binary vector of 69 digits was assigned to
each sequence using a PYTHON language script (Domain study.py, detailed in
Appendix A). This vector indicates the presence (1) or absence (0) of a specific
Pfam domain and its relative position in order from N-terminus to C-terminus,
including the existence of tandem repeats. The amino acid sequences of the
di↵erent proteins, in FASTA format, were retrieved from the NCBI database,
using the Batch Entrez Tool (http://www.ncbi.nlm.nih.gov/sites/batchentrez
(Accessed in November 2015)). Finally, a matrix was generated that included
the GI number, the binary vector, and the associated domain architecture
(DA). We define DA as the linear composition of domains of a given sequence
in N-terminal to C-terminal order. Only sequences that contained a single cat-
alytic GH2C domain, with coverage higher than 70%, were selected for further
analysis. The set of DAs was refined to take into account C-terminal sequences
corresponding to domains not identified by Pfam. We took into consideration
the presence or absence of an extra C-terminal sequence, its length and existing
homology to stablish a classification of the selected proteins. For this analysis,
the protein sequences were also analyzed using the Interpro platform (Mitchell
et al., 2015) in order to get information complementary to that provided by
Pfam. The pipeline for DA analysis is sumarized in the Figure 3.7.
3.7.4 Phylogenetic analysis
The sequence of the catalytic domain (GH2C) was extracted for a selec-
tion of proteins representative of the di↵erent domain architectures (DAs).
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Figure 3.7: Pipeline followed for the obtention of the GH2 domain composition and tree
construction.
Alignment of the GH2C sequences was performed using Clustal O MSA
(Sievers et al., 2011) and CLCsequence viewer (QIAGEN). Trees were built
using Maximum Likehood Parsimony algorithm with JTT matrix (Jones
et al., 1992) and a boostrap of 100 replicates using MEGA6 software
(Tamura et al., 2013). Results were visualized on Dendroscope Software
(Huson and Scornavacca, 2012) and represented using FigTree software
(http://tree.bio.ed.ac.uk/software/figtree/). For the classification of proteins
with unidentified C-terminal domains, these sequences stretches were extracted
and aligned as described above. Subclusters were obtained from the resulting
phylogenetic trees (not shown).
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4.1 Production of Thermotoga maritima
 -galactosidase
PQE-80L was chosen as expression vector for the production of TmLac
carrying a His-tag on its N-terminal end. This vector has a promoter-operator
region containing two sequences of the lac operator that increase repressor
a nity in absence of an inducer, reducing the possibilities of undesired basal
expression. Since gene expression may be decreased by the presence of rare
codons, the TmLac sequence was analyzed with “Rare Codon Calculator”
software from NIH MBI Laboratory for Structural Genomics and Proteomics
Server (http://nihserver.mbi.ucla.edu/RACC/). Up to 59 of the 65 arginine
residues existing in the protein are encoded by rare codons in E.coli, some of
them in tandem repeats, which represent 9% of total codons. Therefore, we
compared TmLac production using two host strains: XL1-Blue, a regular strain
for heterologous gene expression, and ROSSETA2, which contains the plasmid
pRARE2, that encodes for 12 tRNAs corresponding to rare codons in E. coli.
Expression was much more e cient in the latter strain (Figure 4.1).
Recombinant, histidine-tagged TmLac was purified from induced cultures
of E. coli ROSETTA2 transformants by heating treatment, followed by a
clarification step by centrifugation and a nity chromatography through a
nickel column. Samples at di↵erent steps of the purification protocol were
analyzed by SDS-PAGE (Figure 4.2). TmLac migrated as a prominent band
in the crude extract corresponding to the expected mass of 129 kDa and
was recognized by an anti-histidine antibody in a immunoblot assay. After
heat treatment (85oC) most of the endogenous E. coli proteins precipitated
whereas, a significant fraction of TmLac was recovered in the soluble fraction
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Figure 4.1: Di↵erences in TmLac gene expression between strain XL1-Blue (TmLac-X)
and ROSETTA2 (TmLac-ROS). TmLac from a cellular extract of IPTG induced cultures
was analyzed by SDS-PAGE and immunolabelled with anti-HIS antibodies. The band
corresponding to the expected size of TmLac is shown with an arrow.
in agreement with the thermophile nature of the enzyme. This single step
treatment rendered a TmLac sample with 95% of purity. Some of the minor
bands of lower size were recognized by the anti-His antibody suggesting that
they were possibly caused by proteolytic cleavage of the protein at exposed
loops that did not compromise the assembly. Further purification by nickel-
a nity column resulted in a preparation with a higher ratio of full length to
fragmented enzyme.
To determine the molecular mass of native TmLac, the purified protein was
analyzed by size exclusion cromatography (Figure 4.3). The protein eluted at
a volume corresponding to ca. 800 kDa (±200 kDa). This result indicates
that the quaternary structure of the enzyme is composed of 5-9 subunits. The
enzyme showed tendency to aggregate at this concentration since two peaks
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Figure 4.2: SDS-PAGE analysis of protein samples obtained during the purification process.
Lane A soluble extract. Lane B soluble protein after heat treatment (85oC, 15 min.). Lanes
C and D protein recovered after nickel-a nity cromatography. Lane M molecular mass
markers. Protein bands were deleted by Coomasie blue R250 staining (lanes A-C ) or by
immunoblotting with an anti-His antibody (Santa Cruz Biotech, sc-803) (lane D). Bands
corresponding to TmLac and proteolytic fragments (f1 and f2) are indicated by arrows.
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Figure 4.3: Size exclusion cromatography of TmLac. A TmLac sample (2.5 mg/ml) was
injected in a Superdex 200 column 10/300 (GE-Healthcare) previously equilibrated with
bu↵er (50 mM phosphate bu↵er pH 7.0, 150 mM NaCl) and eluted with 2 column volumes at
0.5 ml/min. Peaks corresponding to native TmLac (3) or to aggregates equivalent to 12-mer
(2) or 20-mer (1) are indicated. Red curve corresponds to the molecular mass standard
(Bio-Rad, cat #151-1901). A = Thyroglobulin (bovine) (670 kDa); B =  -globulin (bovine)
(158 kDa); C = Ovalbumin (chicken) (44 kDa); D = Myoglobin (horse) (17 kDa); Vitamin
B12 (1.35 kDa).
of higher molecular mass, corresponding to a mass equivalent to ⇠12 and ⇠20
monomeric units, were also observed in the chromatogram.
4.2 TmLac covalent immobilization
TmLac covalent immobilization was assayed using an epoxy-activated resin
as support. Purified enzyme was incubated with epoxy-coated magnetic beads
at high pH and in the presence of ammonium sulphate. A control sample of
enzyme without beads was incubated in the same conditions. After incubation,
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the beads were captured using a magnet to separate the unbound fraction, and
then treated with Tris bu↵er to wash out loosely bound enzyme and block
the remaining free epoxy groups. Upon incubation, the control sample showed
 -galactosidase activity whereas none was detected in the not-bound fraction
nor in the washing solution, indicating that virtually 100% of the enzyme was
linked to the epoxy beads (20 mg of enzyme/g of beads). Equivalent amounts of
free and bound enzyme were incubated under denaturing conditions that would
disassemble the oligomeric form of the enzyme and consequently released the
non-covalently linked monomers from the beads. The amount of TmLac was
60% indicating that 40% of the monomers were bound covalently (Figure 4.4).
Immobilized enzyme showed higher activity than the free form using either
pNP- -Gal or lactose at di↵erent concentrations as substrates (Figure 4.5).
Activity of both free and bound enzyme, using semi-skimmed milk as the
substrate, was similar to that obtained with a solution of 5% lactose (ca.
the concentration of lactose in milk) (Figure 4.5 B). This result indicates the
absence of a matrix e↵ect in the milk that compromises the activity of TmLac.
Thermal stability of the enzyme after low temperature incubation (4oC) was
analyzed.  -Galactosidase activity of concentrated enzyme (> 0.3 mg/ml),
either in free or bound form, was stable for several weeks. In contrast, diluted
free enzyme (6 µg/ml) showed significant destabilization, loosing activity
progressively down to 50% after 6 hours of cold incubation. However, the
activity of the bound enzyme, was stable at the same concentration for the
same time (Figure 4.6).
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Figure 4.4: TmLac released from the support after denaturing conditions. A A duplicate
sample of bound enzyme (b1, b2) (0.2 mg/ml) was incubated with 1% of SDS at 95oC
during 10 minutes to induce holoenzyme disassembly and the release of non-covalently linked
subunits from the beads. An equivalent amount of free enzyme (f1, f2) was treated in the
same conditions. After centrifugation of the sample (15.000 g x 10 min), the supernatant
was analyzed by SDS-PAGE and Coomassie staining. B Band intensity was quantified with
software Quantity-One (Bio-Rad). Error bars indicate standard deviation of duplicates.
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Figure 4.5:  -Galactosidase activity of free (dark blue) and bound (light blue) TmLac was
assayed with di↵erent substrates. A pNP- -Gal (5 mM); B lactose from milk or bu↵ered
solutions, at di↵erent concentrations. Error bars indicate standard deviation of triplicates.
Figure 4.6: Activity of free and bound enzyme after incubation at 4oC.  -Galactosidase
activity was measured with pNP- -Gal using free or bound enzyme diluted at 6 µg/ml and
kept at 4oC for the indicated times. A freshly diluted sample of free enzymes was analyzed
at each time as a control.
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4.3 Production and analysis of hybrid
TmLac CBM enzymes
We have assayed non-covalent attachment to polysaccharides with hybrid
versions of TmLac containing carbohydrate binding modules. This study also
sought to obtain basic information about the binding a nity to chitin or
cellulose of previously uncharacterized CBMs.
4.3.1 Production of hybrid Thermotoga maritima
 -galactosidase fused to di↵erent CBMs
Four CBMs from di↵erent families were selected: CBM2 from Pyrococcus
furiosus chitinase A (ChiA), CBM5 from P. furiosus chitinase B (ChiB), CBM9
from Thermotoga maritima Xylanase A and CBM19 from Saccharomyces
cerevisiae Cts1 chitinase. These domains were fused to the C-terminal
end of TmLac and the hybrid enzymes were characterized. Recombinant
TmLac CBMs were produced in E. coli. Soluble extracts before and after a heat
treatment were analyzed by SDS-PAGE (Figure 4.7). The electrophoretical
mobilities of recombinant proteins were in agreement with the molecular
masses of TmLac CBM5 (136 kDa), Tmlac CBM2 (148 kDa), Tmlac CBM2
(139 kDa) and TmLac CBM19 (138 kDa) predicted by ProtParam (Walker
et al., 2005). The hybrids with CBMs from thermophilic sources (CBM9,
CBM5 and CBM2) showed a resistance to heat treatment similar to the
wild-type enzyme. However TmLac CBM19 was not recovered in the soluble
fraction after heating, probably because the denaturation of the CBM19
module triggered the aggregation of the enzyme. Therefore, this construct
was discarded from further experiments.
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Figure 4.7: Soluble protein of cellular extract from E. coli transformants expressing
wild-type or hybrid enzymes. SDS-PAGE and Coomassie blue staining were carried out
with clarified samples before (C) and after heating 85oC during 5 minutes (HT). TmLac-
ROS, TmLac CBM9-ROS and TmLac CBM19-ROS were induced at 37oC for 5 hours.
TmLac CBM5-ROS was induced at 37oC for 3 hours and TmLac CBM2-ROS at 16oC for
16 hours. Bands corresponding to full-length recombinant proteins are marked in yellow.
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4.3.2 Study of carbohydrate binding modules as im-
mobilization tags
Substrate a nity (for cellulose or chitin) and binding specificity was mon-
itored for the TmLac thermoresistant hybrids. Preliminary assays indicated
that binding to chitin at pH 6.5 occurred with high a nity (12 mg/g of sup-
port) both for wild-type and hybrid enzymes, indicating that this represented
non-specific binding (not shown). Likely this results from ionic interactions
between partially deacetylated, positively charged, chitin and proteins with
negative charge at this pH. Therefore, for further studies, binding to chitin at
pH 6.5 was not considered. Incubation with cellulose or chitin at pH 6.5 or 8.5
was carried out in parallel to control samples without polysaccharides. After
incubation of the hybrids with the support, bound enzyme was subjected to
several washing steps and finally analyzed by SDS-PAGE in parallel to control
samples. The sample containing enzyme bound to the support (B, in Figure
4.8) was compared to that of total enzyme at the control (C, in Figure 4.8).
Binding of TmLac CBM5 to cellulose or chitin was similar to that of the wild-
type enzyme, therefore representing unspecific adsorption (i.e independent of
the CBM). This construct was therefore not included in further studies. In
contrast, the fractions of Tmlac CBM9 and TmLac CBM2 bound to cellulose
were significantly higher than that of the wild-type, both at pH 6.5 and 8.5.
This was also the case for the binding of TmLac CBM2 to chitin. In all these
instances binding of the hybrid enzyme was higher than for endogenous E.
coli proteins. This is indicative of the binding specificity of the support for
chimeric enzymes, suggesting that protein tagging with CBM2 or CBM9 may
be used for one-step immobilization and purification on cellulose or chitin at
selected pH values. To carry out a more quantitative evaluation of the binding
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Figure 4.8: Binding a nity of the hybrid and wild-type enzymes specificity analysed by
SDS-PAGE. Protein extracts were incubated during 4 hours with acid-washed cellulose (CE)
or chitin (CH) in parallel to control samples without support (C) at pH 6.5 or pH 8.5. Bands
corresponding to full-length recombinant proteins are marked in yellow.
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Figure 4.9:  -Galactosidase activity of wild-type and Tmlac CBM hybrids with 5 mM pNP-
 -Gal. Error bars indicate standard deviation of triplicates. Asterisk indicate significant
di↵erence with wild-type enzyme (p < 0.05).
properties of TmLac CBM2 and TmLac CBM9, the hybrids and the wild-type
enzyme were purified. The specific activity of these enzymes was measured us-
ing pNP- -Gal as substrate (Figure 4.9). TmLac CBM2 had the same specific
activity as wild-type TmLac, whereas Tmlac CBM9 showed to be around 30%
more active than the wild-type enzyme.
To compare the binding e ciency of the di↵erent enzymes equal amounts of
protein (⇠1 µM) were incubated with cellulose or chitin. Tmlac CBM9 did not
bind significantly to chitin at pH 8.5, whereas Tmlac CBM2 showed a binding
e ciency of around 70% of the total enzyme. Immobilization of both hybrids to
cellulose at pH 6.5 was around 60-70%, representing 8 mg enzyme/g of support.
This binding was ca. 2-fold more e cient than at pH 8.5 (Figure 4.10).
Binding stability of the hybrid enzymes to the support was studied under
conditions that mimic those employed for the enzymatic assays with TmLac
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Figure 4.10: Binding e ciency of di↵erent TmLac hybrids to acid-washed cellulose (CE)
or chitin (CH) at di↵erent pH values, compared to wild-type enzyme. Error bars indicate
standard deviation of triplicates.
(pH 6.5 and 75oC). Moreover, we tested whether sugars like glucose or galactose
released from lactose hydrolysis, may interfere with CBM mediated binding.
The bound enzyme was incubated for 30 minutes in the presence or absence of
a glucose-galactose mix. Afterwards the protein that remained attached to the
support and that released to the soluble fraction was analyzed by SDS-PAGE
(Figure 4.11). Binding of TmLac CBM2 was stable in all conditions tested.
In the case of TmLac CBM9 the treatment with glucose and galactose caused
detachment of the protein from cellulose, but not from chitin. These sugars
seem to displace cellulose from the CBM9 binding site promoting the release
of the hybrid enzyme. Low a nity of TmLac CBM9 to chitin, which is similar
to the wild-type enzyme, is probably not mediated by the CBM and therefore
it was not influenced by sugar addition.
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Figure 4.11: Analysis of the binding stability of TmLac hybrids to cellulose or chitin. Hybrid
enzymes were immobilized on cellulose (CE) at pH 6.5 or chitin (CH) at pH 8.5. Bound
enzyme was incubated at 75oC for 30’ in assay bu↵er (left panel) or Glu/Gal mix (150mM
each) in the same bu↵er (right panel). Released (R) and bound (B) fractions after this
treatment were analyzed by SDS-PAGE and Coomasie blue staining.
4.4 Milk lactose hydrolysis
The most common industrial method to remove lactose from milk is the
enzymatic hydrolysis to galactose and glucose. This reaction is achieved using
lactase, generally  -galactosidase from the yeast Kluyveromyces lactis. We have
analyzed three commercial lactose-free milk brands marketed in Spain to check
whether the enzyme is present in the final product. Samples of lactose-free
or regular milk were analyzed by SDS-PAGE after treatment with rennin to
remove casein, the major milk protein (Figure 4.12). A di↵erential band was
detected in lactose-free milk products with the same size as the major band of
K. lactis commercial lactase, with an expected molecular weight of 124 kDa.
Moreover,  -galactosidase activity was detected in lactose-free milk but not in
regular milk using pNP- -Gal (not shown).
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Figure 4.12: SDS-PAGE analysis of semi-skimmed milk after an aspartic protease treatment
(1.52 µg/ml) (Rennet (SIGMA)) and 4 mM of CaCl2 during 1 hour at 30oC. The product was
centrifuged at 15500 g during 20’, and concentrated 5-fold by ultrafiltration through a pore
size of 20 kDa (Pierce). The three brands analyzed were: PA: Pascual; HA: Hacendado and
PU: Puleva. Asterisk indicate lactose free milk products. Klac corresponds to Kluyveromyces
lactis lactase from SIGMA (cat. G3665). The di↵erential band found in lactose-free milk is
indicated with an arrow.
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We have tested the suitability of free and immobilized TmLac to be used
for milk lactose hydrolysis. In the assays, lactose at a concentration of 5%,
similar to that found in milk, was analyzed. The kinetics with 0.06 mg/ml free
wild-type enzyme was similar to that obtained with the covalently immobilized
version on epoxy-activated beads at the same concentration (Figure 4.13 A).
In both cases 100% hydrolysis was obtained after 3 hours incubation at 75oC.
Subsequently, we determined the number of times that the immobilized enzyme
could be recycled to hydrolyze 5% of lactose in batches of 3 hours. The
performance of the enzyme was not seriosuly compromised after 4 cycles of
reutilization, hydrolyzing more than 90% of the initial sugar amount (Figure
4.13 B). Even after 8 cycles of reutilization, the enzyme was able to hydrolyze
more than 60%.
A similar study was carried out with non-covalently immobilized enzyme
though CBMs. The hybrid TmLac CBM9 was discarded for this application
since binding to cellulose was shown to be unstable in the presence of glucose
and galactose concentrations in the range of those released after 5% lactose
hydrolysis (Figure 4.11). In contrast TmLac CBM2 had shown an e cient and
stable binding to cellulose or chitin (Figures 4.10, 4.11). TmLac CBM2 (0.08
mg/ml) immobilized either on cellulose or chitin was able to complete hydrolysis
of lactose in 3.5 hours at a similar rate (Figure 4.14 A). Consecutive batches of
5% lactose were incubated 3.5 hours with the recycled enzyme for and the extent
of lactose hydrolysis was determined after each batch. The e ciency of the
recycled enzyme immobilized either on cellulose or chitin decayed progressively
after the first batch and reached 30% of the original activity in the 6th batch
(Figure 4.14 B).
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Figure 4.13: Lactose hydrolysis with epoxy-immobilized TmLac. A Free and bound TmLac
(0.06 mg/ml) were incubated with 5% lactose for the indicated times at 75oC. B Bound
TmLac was incubated with 5% lactose during 3h at 75oC in 10 repeated cycles. The extent
of hydrolysis was calculated from the molar ratio of released glucose to initial lactose. Error
bars indicate standard deviation of triplicates.
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Figure 4.14: Lactose hydrolysis with hybrid TmLac CBM2 immobilized on cellulose or
chitin. A Bound TmLac (0.06 mg/ml) was incubated with 5% lactose for the indicated
times at 75oC. B Bound TmLac was incubated with 5% lactose during 3.5 hours at 75oC in
6 repeated cycles. The extent of hydrolysis was calculated from the molar ratio of released
glucose to initial lactose. Error bars indicate standard deviation of triplicates.
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4.5 Structural analysis of TmLac
4.5.1 Homology based model of TmLac
Since the structure of TmLac has not been fully solved yet, we constructed
a structural model of TmLac to facilitate the design of mutants that could
improve the transglycosylation capability of the enzyme (Section 4.6). The
 -galactosidase from E. coli, EcLac (PDB code 3CZJ) which has the highest
sequence identity (ca. 40%) with TmLac was used as template (Figure 4.15 A
(left)). The resulting structure was formed by an ↵/  barrel, surrounded by
four  -sandwich domains (two N-terminal and two C-terminal) in agreement
with the typical architecture of  -galactosidases from the GH2 family. TmLac
shows an extra C-terminal extension of ca. 100 residues (Figure 4.16) with a
predicted  -sandwich fold (Figure 4.15 B), present in  -galactosidases related
with Thermotoga but not in other homologous enzymes. This domain was
modelled using as template a CARDB-like domain from Pyrococcus furiosus
which shares 20% of sequence identity (Figure 4.15 A (right)). A detailed
study of the catalytic site revealed that residues from loops involved in catalysis
or substrate binding in EcLac are highly conserved (70% identity) in TmLac,
suggesting a good quality of the model in this region (Table 4.1).
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Figure 4.15: Structural modeling of TmLac. A. Molecular models of the main body of
TmLac (residues 1-983) (left panel) and C-terminal domain (residues 984-1084) (right panel).
N-terminal and C-terminal ends of each fragment are indicated. The ↵/ -barrel surrounding
the catalytic residues is coloured in violet, whereas the accompanying  -sandwich domains,
homologous to other GH2 enzymes, are coloured in blue, orange, green and red. The  -
sandwich specifically found in TmLac and other  -galactosidases from the Thermotoga genus
is depicted in grey B. Schematic representation of the domain architecture of TmLac in
comparison with canonical  -galactosidases from the GH2 family.
Table 4.1: Sequence alignment of loops involved in the active site of EcLac. Di↵erential
residues between EcLac and Tmlac are underlined.
76
CHAPTER 4. RESULTS
Figure 4.16: Alignment of  -galactosidases from T. maritima (TmLac) and E. coli (EcLac)
(Uniprot codes Q56307 and B8LFD6, respectively). A coloured line on top of TmLac
sequence indicates the extension of the catalytic domain (green), the  -sandwiches common
to other GH2 enzymes (blue, orange, purple, red) and the additional  -sandwich found in
TmLac (grey).
77
CHAPTER 4. RESULTS
4.5.2 Crystallographic analysis
Crystallographic resolution of TmLac was addressed by the group of Dr.
Julia Sanz Aparicio from the “Instituto de Qu´ımica F´ısica Rocasolano” (CSIC,
Madrid). Initial attempts to di↵ract TmLac crystals, gave a fairly good
resolution around the active site region. However, the resolution was poor
at the loops that interconect  -sandwich domains, possibly as consequence
of the high flexibility of these regions. A possible solution in some in-
stances is the introduction of point mutations that reduce the number of
conformations of the loops. Using the Surface Entropy Reduction predic-
tion (SERp) server (Goldschmidt et al., 2007) three di↵erent groups of mu-
tations were suggested: 1) E242A/E243A/E244A; 2) E697A/K698A/K699A;
3) K1029A/E1030A/K1031A, located at di↵erent regions, all of them distant
from the catalytic pocket (Figure 4.17). Thermal stability of each mutant was
analyzed by SDS-PAGE. Soluble protein remaining after heat treatment was
similar in mutants and wild-type (Figure 4.18), indicating that mutations do
not a↵ect thermal stability of the protein. Nevertheless, after obtaining crys-
tals with di↵erent crystallization patterns the structure with the best resolution
(3.5 A˚) was still about the same obtained with the wild-type TmLac (Figure
4.19 A). Di↵raction spectra obtained so far do not allow a detailed resolution
of the secondary and tertiary structure. However, they are good enough to
provide a picture of the overall octameric quaternary structure of the protein
(Figure 4.19 B).
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Figure 4.17: Locations of the mutations carried out to reduce the surface entropy in the
TmLac model. The relative position of the groups of mutated residues on the protein domains
is indicated by arrows in the scheme shown on the top and marked by yellow contoured areas
in the structural model.
Figure 4.18: Soluble protein from E. coli extracts expressing wild-type and mutant enzymes
designed by the SERp server. SDS-PAGE and Coomassie blue staining of samples before
(C) and after heat treatment at 85oC during 5 minutes (HT). Heterologous gene expression
was induced at 37oC for 3 hours in all cases. Bands corresponding to full-length recombinant
proteins are marked in yellow.
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Figure 4.19: Crystallographic study of TmLac. (A) Crystal of wild-type TmLac. (B) Two
views of the TmLac octamer in solvent accessible surface at 3.5 A˚ resolution.
4.6 Improvement of the tranglycosylating ac-
tivity of TmLac
4.6.1 Analysis of GOS synthesis by wild-type TmLac
Synthesis of GOS by TmLac was assayed using 25% of lactose as substrate
since high lactose concentration favour the transglycosylation reaction (Ga¨nzle,
2012). The performance of both free and covalently bound enzyme to an epoxy
activated resin was compared. As a consequence of the retaining mechanism
of the enzyme (Figure 1.4), both hydrolysis and transgalactosylation of
lactose proceed through a covalent intermediate of the enzyme linked to the
galactosyl moiety. In both reactions a glucose molecule is released in the
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Figure 4.20: Glucose release by free and covalently bound TmLac (3 µg/ml). The enzyme
was incubated with 25% lactose at 75oC with continuous shaking.
first step. Therefore, the kinetic of glucose production can be taken as an
estimation of the total activity (hydrolysis plus transglycosylation) of the
enzyme. The rate of glucose release was similar for free and bound enzyme
forms, reaching saturation at a concentration around 110 mM, which represents
the consumption of around 16% of the initial lactose present in the medium
(Figure 4.20). This enzymatic arrest is likely due to product inhibition as it
has been described for other  -galactosidases (Boon et al., 1999; Vera et al.,
2011).
Reaction products of free and bound TmLac obtained after 5 hours of reac-
tion were compared after analysis by anion exchange chromatography. Both en-
zyme forms yielded the same elution profile with two major transglycosylation
products with retention times of 5.45 and 7.23 min. These GOS were identi-
fied as  -6’-galactosyl-lactose and  -3’-galactosyl-lactose, respectively, by com-
parison with retention times of commercial standards (Carbosynth, UK). The
chemical structure of these trisaccharides was confirmed by NMR carried out
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Figure 4.21: Chromatogram of the products obtained after 5 hours incubation of lactose
(25%) with free or covalently bound enzyme. Peaks corresponding to glucose and galactose
(Glc + Gal), lactose (Lac), and two galacto-oligosaccharides (GOS-1:  -6’-galactosyl-lactose;
GOS-2:  -3’-galactosyl-lactose) are indicated.
by the group of Prof. FJ Can˜ada from “Centro de Investigaciones Biolo´gicas,
CIB-CSIC”. Quantification of chromatographic peak areas revealed that wild-
type enzyme produced  -3’-galactosyl-lactose and  -6’-galactosyl-lactose with
a molar ratio of 3:1 (Figure 4.21).
4.6.2 Mutant design
A set of mutations directed to the active site of TmLac was designed with the
aim of increasing GOS yield, changing the profile of transglycosylation products
or exploring the structural basis of the intrinsic transglycosylating properties
of the enzyme. Rational design was based on a structural model of TmLac
docked with a molecule of  -3’-galactosyl-lactose, the major transglycosylation
product of the wild-type enzyme (Subsection 4.6.1). This complex (Figure
4.22) can be considered an analogue of the reaction intermediate, where the
enzyme is covalently linked to a galactosyl moiety and a new lactose molecule
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binds to the active site to act as the galactosyl acceptor.
The docking analysis showed a set of residues that may form hydrogen
bonds with the galactosyl moiety at the non-reducing end of  -3’-galactosyl-
lactose, namely D191, H369, N440, E441, E507, H510, W538 and N574. These
residues would conform the -1 subsite, using the nomenclature stablished by
Davies et al., 1997 and represent the binding sca↵old of the galactosyl moiety
covalently bound to the enzyme in the reaction intermediate (Figure 4.22).
Most of these residues, considered to be essential for enzyme function, are
highly conserved among GH2  -galactosidases. E507 and E441 (homologous
to EcLac E537 and E461), would be the putative catalytic pair (nucleophile
and acid/base respectively) (Juers et al., 2001). In EcLac, D191 is involved
in Na+/K+ binding (described as  -galactosidase activators), H369, N440 and
H510 stabilize the transition-state, and W538 binds lactose in the so-called deep
mode (Roth and Huber, 1996; Huber et al., 2001; Juers et al., 2001; Xu et al.,
2004; Juers et al., 2012; Wheatley et al., 2012). The substitution of many
of these residues in EcLac rendered an inactive enzyme and therefore they
were discarded as candidates for mutagenesis. Only residue N574 showed some
sequence divergence among GH2 enzymes with Asp at an equivalent position in
some cases (Figure 4.22 B). Substitution N574D was designed to study whether
this change had a functional role. Mutants N574A and N574S were generated
in order to disrupt the putative hydrogen bond between the galactosyl moiety
covalently bound to the enzyme in the reaction intermediate and the N574
residue. The rationale behind this was to increase the rotational freedom of this
group facilitating the coupling to the lactose molecule that acts as galactosyl
acceptor.
Subsites +1 and +2, that bind the galactosyl and glucosyl moiety of the
acceptor lactose, respectively, would involve fewer residues than subsite -1
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Figure 4.22: Design of TmLac mutants. A. Left panel. Detail of TmLac active site high-
lighting the catalytic residues (red) and the residues targeted for site-directed mutagen-
esis (orange).  -3’-galactosyl-lactose is depicted with the galactosyl moiety at the non-
reducing end in blue. The rest of the molecule, coloured in violet, represents the lacto-
syl moiety acting as acceptor of the galactosyl group during transgalactosylation. Right
panel. Schematic representation of the reaction intermediate in transglycosylation reac-
tion. The galactosyl moiety covalently linked to the -1 subsite is depicted in blue. The
acceptor lactose molecule bound to +1/+2 is coloured in violet. B. Sequence alignment
of TmLac with other GH2  -galactosidases with transgalactosylating activity. Sequences
around the residues targeted for site-directed mutagenesis are shown. The relative posi-
tion of those sequences within specific TmLac domains is schematically represented above.
Colour codes for the di↵erent domains are the same as those indicated in Figure 4.15.
Genebank codes for the proteins are: T. maritima: AAD36268.1, E. coli : AAA24053.1,
L. delbrueckii : CAI98003.1, K. lactis: AAA35265.1, B. longum sub infantis: AAL02052.1,
L. acidophilus LacL: ABK59934.1, L. acidophilus LacM: ABK59935.1, L. reuteri LacL:
ABF72116.1, L. reuterii LacM: ABF72117.2, L. plantarum LacL: CAZ66936.1, L. plan-
tarum LacM: CAD65570.1.
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and should not be as critical for enzyme activity. W959 and N574 are in
contact to both galactosyl and glucosyl groups of the lactose acceptor. The
W959 residue is conserved in bicistronic  -galactosidases, despite the fact that
this residue is located in a di↵erent subunit. In the case of Kluyveromyces
lactis  -galactosidase the equivalent position is occupied by a cysteine residue
(Figure 4.22 B). Subsite +2 may be conformed by F571 and D568 residues. The
functionality of W959, F571 and D568 in the transglycosylation reaction was
tested with the mutants W569C, W959F, W959A, F571L, D568A and D568S.
Finally, V93 and V94 residues, located close (around 4 and 7 A˚ respectively)
to the terminal glucose moiety were mutated to Thr or Gln in order to mimic
 -galactosidases with high transgalactosylating activity (Figure 4.22 B). These
substitutions may stabilize the binding of a more extended galactosyl acceptor,
for example a trisaccharide, to yield a tetrasaccharide. Mutants V93T, V94T
and V94Q were generated to test this hypothesis.
4.6.3 Analysis of mutant enzymes
Production of mutant enzymes by E. coli compared to the wild-type was
evaluated by SDS-PAGE analysis of soluble extracts of enzyme-producing
transformant clones. As shown in Figure 4.23, TmLac mutants had expression
patterns similar to wild-type enzyme, except for N574S and W959F which
were produced in significantly lower amounts. However, none of the introduced
mutations seem to change the thermal stability of the enzyme, since the fraction
of soluble enzyme recovered after heat treatment is similar to that obtained with
the wild-type Figure 4.23.
As previously mentioned, since glucose is released both for hydrolysis and
transgalactosylation, initial velocity of glucose production can be used to
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Figure 4.23: Expression of TmLac mutants in E. coli. SDS-PAGE analysis of crude soluble
extracts (C) and soluble extract after heat treatment (HT) at 85oC for 5 minutes. Wild-type
and mutant TmLac versions are marked in yellow.
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Table 4.2: Total activity of the di↵erent. Relative values to wild-type enzyme are shown in
parenthesis (* p < 0.01).
Enzyme Total activity
(µmol Glc · min 1 ·µg protein 1)
wild-type 4.4 ± 0.9 (100%)
V93T 4.15 ± 0.08 (94%)
V94T 3.8 ± 0.3 (86%)
V94Q 4.3 ± 0.7 (98%)
D568S 4.8 ± 0.2 (110%)
D568A 5.17 ± 0.17 (120%)
F571L 3.1 ± 0.2 (70%)
N574A 1.4 ± 0.3 * (31%)
N574S 0.36 ± 0.06 * (8%)
N574D 4.3 ± 0.3 (97%)
W959F 0.22 ± 0.06 * (5%)
W959C 0.94 ± 0.05 * (21%)
W959A 2.0 ± 0.2 * (45%)
F571L/N574S 0.41 ± 0.4 * (9%)
F571L/N574A 0.30 ± 0.3 * (7%)
calculate the total activity (hydrolysis plus transglycosylation) of the enzyme
(Table 4.2). Transformants with TmLac substitutions N574A and N574S
showed a drastic reduction of activity (down to 31% and 8% of the wild-
type, respectively) whereas N574D substitution had no significant e↵ect on
total activity. The reduction of activity for N574S can be correlated with
the decreased enzyme synthesis (Figure 4.23). The lower activity observed for
W959F (5% of the wild-type) may be also explained by decreased expression
(Figure 4.23). However, substitution of W959 by non-aromatic residues
(W959C and W959A) caused a significant reduction of the total activity (to
21% and 45% of the wild-type, respectively) despite the fact that the enzyme
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Figure 4.24: Kinetics of wild-type TmLac. A. Glucose release. B. Galacto-oligosaccharide
production. Symbols: closed triangles: glucose; light blue dots:  -6 ’-galactosyl-lactose; dark
blue dots:  -3 ’-galactosyl-lactose. Error bars indicate standard deviation of triplicates.
amount was not altered (Figure 4.23). Total activity of the rest of mutants
(V93T, V94T, V94Q, D568S, D568A, F571L) was similar to that of the wild-
type. Therefore, only mutations W959C and W959A caused a significant
decrease in TmLac activity per unit of enzyme mass.
Kinetics of  -3’-galactosyl-lactose,  -6’-galactosyl-lactose production, and
glucose release were analyzed for the wild-type enzyme (Figure 4.24). Glucose
release kinetics revealed that TmLac is progressively inactivated. After 3 hours
of reaction, the rate of glucose production was about 20% of the initial velocity,
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probably as a consequence of enzyme inhibition by product accumulation, as
reported for other  -galactosidases (Boon et al., 1999; Vera et al., 2011). GOS
synthesis also slowed down as the reaction progressed, with a lower rate after
3 hours of reaction for both  -3’-galactosyl-lactose and  -6’-galactosyl-lactose
(Figure 4.24 B).
To compare GOS yield between di↵erent enzyme variants and the wild-type,
the same amount of enzyme (activity units) was used (calculated as initial
glucose release per unit of time) and the reactions were carried out for 5 hours.
Kinetics of glucose release was monitored in parallel as a control (Figure 4.25
and 4.26).
None of the enzymatic versions synthesized novel GOS types compared to the
wild-type. Mutations N574S and N574A, but not N574D, yielded an increase
in the synthesis of  -3’-galactosyl-lactose, around 30% and 40%, respectively,
whereas  -6’-galactosyl-lactose synthesis was not a↵ected significantly (Figure
4.25 A). Similary,  -3’-galactosyl-lactose synthesis was increased around 40%
with mutant F571L (Figure 4.25 B). Substitutions at residues D568, V93
and V94 did not a↵ect transglycosylation e ciency nor the product profile
of TmLac (Figure 4.26A and 4.26 C). Substitution W959F did not cause a
significant change in the transglycosylating properties of the enzyme either.
However, mutations W959C and W959A reduced drastically (around 80%)
the synthesis of  -3’-galactosyl-lactose but not so remarkably that of  -6’-
galactosyl-lactose (Figure 4.26 B). Consequently, the ratio of  -3’-galactosyl-
lactose/ -6’-galactosyl-lactose which is 2.6 for the wild-type enzyme, was
reduced to 1 and 0.7, for W959C and W959A, respectively.
Substitutions with higher GOS production were combined, generating
mutants F571L/N574S and F571L/N574A. The resulting enzymes showed a
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Figure 4.25: E↵ect of substitution of residues F571 and N574 on the synthesis of galacto-
oligosaccharides (right panels):  -3’-galactosyl-lactose (dark blue bars) and  -6’-galactosyl-
lactose (light blue bars). Error bars indicate standard deviation of triplicates. Asterisks
indicate significant di↵erences (p < 0.01) compared to wild-type data. Kinetics of glucose
release is shown on the left panels as a control.
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Figure 4.26: E↵ect of substitution of residues D568, W959, V93, and V94 on the synthesis
of galacto-oligosaccharides (right panels):  -3’-galactosyl-lactose (dark blue bars) and  -6’-
galactosyl-lactose (light blue bars). Error bars indicate standard deviation of triplicates.
Asterisks indicate significant di↵erences (p < 0.01) compared to wild-type data. Kinetics of
glucose release is shown on the left panels as a control.
91
CHAPTER 4. RESULTS
significant reduction in activity compared to the wild-type (Table 4.2). Both
double-mutants yielded an increased synthesis of  -3’-galactosyl-lactose over
the wild-type (1.9 and 1.7 fold respectively) representing also a significant
increment over the single mutants F571L and N574S (Figure 4.25 C).
4.7 Phylogenetic analysis of GH2 enzymes
4.7.1 GH2 Domain Architectures (DAs)
A phylogenetic study of the GH2 family to which TmLac belongs, was carried
out with proteins containing the canonical catalytic domain Glyco hydro 2 C
(GH2C) defined in Pfam database. Sequences in which this domain was
absent related with enzymatic activities other than  -galactosidases (e.g.
mannosidases and arabinosidases), were excluded. Also, hybrid enzymes with
additional catalytic modules (e.g. glycosyl transferases, lipases, deacetylases,
kinases, hexoaminidase, etc.) were not considered. All the selected sequences
contain two  -sandwich domains at the N-terminal side of GH2C, identified
in Pfam as Glyco hydro 2 N (GH2N) and Glyco hydro 2 (GH2) (Figure
4.27). These domains correspond to the N-terminal modules described by
Juers et al., (1999) as characteristic of GH2 enzymes. In some cases, the
GH2 domain is absent (DA type 3, Figure 4.27). However, these proteins
contained instead a sequence of similar length to GH2 that likely represents
an equivalent domain not defined in Pfam. Exceptionally, additional N-
terminal domains related to carbohydrate recognition (Ricin B lectin domain)
(Rutenber et al., 1987) or a cell surface adhesion signal (YSIRK signal) (Bae
and Schneewind, 2003; DeDent et al., 2008; Tettelin et al., 2001) were found
(not shown), suggesting that these sequences correspond to surface anchored
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Figure 4.27: Domain architectures of GH2 family. Numbers in parentheses indicate the
number of sequences representative of each DA type, included the Pfam database.
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galactosidases. The classification of DAs rendered five groups (DA types)
shown in Figure 4.27. One of the protein groups with higher number of
representants (DA type 1 with ca. 700 sequences) showed a DA constituted
by the characteristic core of  -galactosidases (GH2N+GH2+GH2C) without
any additional domain. According to GenBank annotations, glucuronidases
are included in this group. A variation of this DA is represented by the large
subunit (LacL) of bicistronic  -galactosidases (DA type 2). These enzymes
have a heterodimeric constitution, formed by the interaction of LacL with a
smaller subunit LacM (78 entries in Pfam, labelled Bgal Small N).
The most frequent topology (DA type 3) contains the Bgal Small N domain
at the C-terminal end of the protein. Three di↵erent subtypes can be discerned.
In most cases (1204 sequences) Bgal Small N is linked to the GH2C through
a  -sandwich domain, of around 100 amino acids, identified in Pfam as
DUF4981 (Domain of Unknown Function). In other cases (185 sequences)
either DUF4981 or GH2 or both were absent, being replaced by sequences of
similar length. In a small set of sequences (50 entries) probably corresponding
to secreted enzymes, there are additional domains appended. For instance, in
some proteins a Laminin G3 domain, related with cell adhesion, is inserted
between the GH2C and the DUF4981 domains. Some sequences contain
modular domains characteristic of extracellular proteins, such as NPCBM or
F5/F8, downstream the Bgal Small N domain (Rigden, 2005).
DA type 4 includes 256 proteins with a C-terminal (Ct) extension of 60-
1053 residues without identified domains. We have classified these sequences
according to the length and sequence similarity of the Ct extension (Table 4.3).
DA type 5 (373 entries) includes proteins with the GH2C followed by
the DUF4982 domain and additional C-terminal extensions (Figure 4.27).
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Table 4.3: Cluster and subcluster classification of DA type 4 proteins with unidentified C-
terminal extensions.
C-terminal signature Length Number of sequences Number of sub-clusters
Ct1 60-100 47 Ct1-1, Ct1-2, Ct1-3, Ct1-4
Ct2 100-150 30 Ct2-1, Ct2-2, Ct2-3, Ct2-4
Ct3 150-200 21 Ct3-1, Ct3-2, Ct3-3
Ct4 200-250 55 Ct4-1, Ct4-2, Ct4-3, Ct4-
4, Ct4-5, Ct4-6, Ct4-7
Ct5 250-300 35 Ct5-1, Ct5-2, Ct5-3, Ct5-4
Ct6 300-350 15 Ct6-1, Ct6-2, Ct6-3
Ct7 350-400 19 Ct7-1, Ct7-2, Ct7-3
Ct8 400-450 21 Ct8-1, Ct8-2, Ct8-3, Ct8-4
Ct9 450-500 2 -
Ct10 500-550 2 -
Ct11 800-850 7 -
DUF4982 probably acts as a linker between GH2C and the C-terminal domains
downstream, in a similar way that DUF4981 does in DA type 3 proteins. Most
proteins of this group (284 sequences) contain C-terminal regions (Cter) of
100 to 550 amino acids with unidentified domains. We have classified them
according to the C-terminal length and sequence identity (Table 4.4). We
considered that DA type 5 proteins deserved special attention because of the
high sequence variability at their C-terminal extension. Therefore, detailed
analysis of this group was carried out including domains described in Interpro
(Mitchell et al., 2015) and not identified in Pfam. Results are shown in Figure
4.28. In a subset of these proteins sequences, di↵erent combinations of Ig-like
domains mostly occurring in cell-wall anchored proteins and other modules
involved in cell adhesion were detected. Many of these sequences show a BIG1-
like domain downstream DUF4982.
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Figure 4.28: Domain architecture of DA type 5 sequences. Coloured and stripped boxes
correspond to domains identified by Pfam and Interpro databases, respectively. Modules
with more than 40% sequence identity compared to BIG1 domains identified by Interpro,
with a coverage higher than 60%, were tagged as BIG1. Letters (a-i) on the right edge of the
figure group sequences with similar DAs. Numbers on top of non-identified regions indicate
approximate number of residues. The architectures corresponding to B. circulans (Bc) and
B. bifidum (Bb) are indicated in red.
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Table 4.4: Cluster and subcluster classification of DA type 5 proteins with unidentified C-
terminal extensions.
C-terminal signature Length Number of sequences Number of sub-clusters
Cter1 100-150 217 Cter1-1, Cter1-2
Cter2 150-200 2 Cter2-1, Cter2-2
Cter3 200-250 2 Cter3-1, Cter3-2
Cter4 250-300 11 Cter4-1, Cter4-2, Cter4-3
Cter5 300-350 4 -
Cter6 350-400 47 Cter6-1, Cter6-2, Cter6-3
Cter7 400-450 5 -
Cter8 500-550 6 -
4.7.2 Phylogenetic analysis of the GH2 catalytic
domain
Figure 4.29 shows a phylogenetic tree constructed using the GH2C modules
of representative sequences from each DA. All the sequences corresponding
to canonical  -galactosidases (DA type 3) clustered in a single group. This
cluster includes subtrees corresponding to bicistronic galactosidases classified
as DA type 2. Interestingly, a subset of type 4 (labelled as Ct 8 3) also clusters
within canonical galactosidases. A search in the Conserved Domain Database
from NCBI (Marchler-Bauer et al., 2015) using the C-terminal region of these
sequences as input identified a sequence stretch of around 50-100 residues
homologous to the central region of Bgal Small N domain. The remaining
type 4 sequences cluster in four di↵erent nodes. Glucuronidases (DA type 1)
are dispersed in three di↵erent nodes. DA type 5 is divided in three blocks.
Two of them cluster with DA type 4 whereas the other one, labelled 5* in Figure
4.29, is described below. The evolutionary analysis may o↵er interesting clues
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Figure 4.29: Phylogenetic analysis of the GH2C domain. The tree was calculated by
Maximum Likelihood method based on the JTT matrix-based model (Jones et al., 1992)
condensed at < 50% bootstrap support. The analysis involved a selection of 380 amino acid
sequences for the di↵erent DAs. Values indicate the DA type. The tree was drawn using
FigTree software (http://tree.bio.ed.ac.uk/software/figtree/). The asterisk mark the subtree
further analysed in Figure 4.30. Arrow indicates the position of the TmLac. Clusters are
coloured by DA, dark grey indicate clusters containing more than one DA.
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about uncharacterized enzymes with potential industrial value. For instance,
enzymes with DA types 2 and 3 show high transglycosylating activity being
able to synyhetise  -(1,3) and  -(1,6) GOS (Crittenden and Playne, 1996).
Commercial synthesis of  -(1,4) GOS is carried out with a  -galactosidase
from Bacillus circulans (Yanahira et al., 1995). A related  -galactosidase from
Bifidobacterium bifidum also shows high transglycosylating e ciency (Goulas
et al., 2009). Both enzymes belong to DA type 5. They carry a BIG1-like
domain downstream the DUF4982 module (Figure 4.28) and their catalytic
domains cluster under the same node (labelled 5* in Figure 4.29 and shown in
more detail in Figure 4.30).
In order to relate the transglycosylating capability of industrially interesting
enzymes with their phylogenetic position, a detailed study of DA type 5 was
carried out. Amino acid residues within the catalytic pocket, potentially
involved in transglycosylation, were identified by a docking study of the
trisaccharide  -(1,4)-galactosyl-lactose into the B. circulans  -galactosidase
structure (Figure 4.31). According to this analysis, one of these residues is
located within the GH2N domain, whereas the other 13 reside in the GH2C
domain. These include the catalytic triad formed by Glu 447 (acid base),
Glu 532 (nucleophile) and Tyr 511 (Ishikawa et al., 2015). Figure 4.32 shows
a sequence alignment of DA type 5* enzymes. Residues potentially involved
in transglycosylation (marked by purple squares) are largely conserved among
sequences containing the BIG1 domain. Exceptions are Tyr 449, which is poorly
conserved and Asp 481 that changes to Asn in many instances, including the
 -galactosidase from B. bifidum. Some DA type 5  -galactosidases lacking the
BIG1 domain, labelled Cter6-2, also show high identity at residues potentially
involved in transglycosylation.
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CHAPTER 5. DISCUSSION
Lactase is among the most relevant enzymes used in the food industry,
mostly because its lactose-splitting hydrolytic activity, but also because of its
transglycosylating capability which is becoming increasingly important. Cur-
rently used industrial lactases belong toKluyveromyces lactis, Aspergillus niger,
and Bacillus circulans, which work optimally under mesophilic conditions.
There is a growing interest to develop new industrial enzymes that operate
at cold temperatures (Nakagawa et al., 2006; Pawlak-Szukalska et al., 2014;
Fan et al., 2015) or high temperatures (Akiyama et al., 2001; Placier et al.,
2009; Torres et al., 2010). The  -galactosidase from the thermophilic bacte-
ria Thermotoga maritima was selected for this project to o↵er an alternative
method for lactose hydrolysis and to improve its potential for GOS synthesis.
The thermostability of the enzyme is a great advantage to purify the protein
overproduced in mesophilic hosts. According to our results, a simple heat treat-
ment allows the purification of the enzyme produced in E. coli to more than
95% of the total protein (Figure 4.2). This represents a significant reduction
in the time and cost of purification for industrial applications.
The main results achieved in this project are discussed below.
5.1 Immobilization
Enzyme immobilization is a useful methodology for industrial applications
since it allows enzyme recycling and working in continuous systems. Stable
attachment of the enzyme to a support also prevents its release to the final
product. This is particularly interesting for food applications, since current
market tendencies favour products without any type of additives. In the
case of lactose-free milk our results show that di↵erent Spanish commercial
brands include significant amounts of lactase (Figure 4.12). Another positive
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aspect of immobilization, specifically when multi-point attachment occurs, is
associated to an increased stability. These features have been studied using
two surface binding methods, covalent cross-linking to epoxy-activated beads
or non-covalent adhesion based on hybrid proteins.
5.1.1 Covalent immobilization
E↵ective covalent immobilization on epoxy-activated resins is highly depen-
dent on the previous adsorption of the enzyme to the support, to bring reactive
groups of the protein (mainly lysine residues) in close contact to epoxy residues
(Mateo et al., 2007a). E cient immobilization normally requires salt addition
at moderate concentrations. This e↵ect varies, depending on the protein ma-
terial and the epoxy resin (e.g. polystyrene, methacrylate, polyvinyl alcohol,
polyacrylamide or silica) (Wheatley and Schmidt Jr, 1999; Mateo et al., 2000;
Torres et al., 2003; Bozhinova et al., 2004). In the case of resins of hydropho-
bic nature (e.g. polystyrene, methacrylate), the e↵ect of the salt has been
attributed to salt-induced hydrophobic interactions between the protein and
the resin, that facilitate the initial adsorption. The support used in this work
was polyvinyl alcohol (PVA) activated with epoxy groups (M-PVA-E02 from
Chemagen). Although PVA is generally considered as a hydrophilic polymer,
published results and our own experience indicate that addition of salt at high
concentrations yields a more e cient protein immobilization. A possible ex-
planation is that the spacer arms used for the functionalization of the support
partially mask the hydrophilic nature of the resin, and may also serve as hy-
drophobic adhesion points for the protein upon salt addition. Another factor
which probably determines immobilization on these supports is the hydropho-
bicity of the protein. The tendency of TmLac to aggregate at high salt con-
106
CHAPTER 5. DISCUSSION
centrations (Figure 4.3) suggests the presence of extended hydrophobic patches
on its surface, that may be involved in salt-induced adhesion to the support.
The pH used during the incubation process with the support is another factor
that may determine binding e ciency. This is because the nucleophilic char-
acter of the lysine residues is enhanced at pH values above their pKa, at which
they are mostly in their deprotonated form. TmLac has the advantage of be-
ing stable after incubation at high pH values up to 11, which allows the use
of high pH values for binding. Under our experimental conditions, 20 mg of
the enzyme were bound per gram of resin. This is probably below the loading
capacity of the support since no enzyme was detected in the unbound fraction
after incubation. Another key aspect for enzyme immobilization is that the
bound enzyme may show di↵erent properties, related with activity or stability,
compared with the free form. Immobilization may cause changes in the cat-
alytic properties due to conformational changes forced by the covalent binding
or by di↵usion limitations for the enzyme, the substrate or the products. Co-
valent immobilization of K. lactis  -galactosidase to glutaraldehyde modified
supports, such as graphite or silica, resulted in reduced activity (Zhou and
Dong Chen, 2001) or reduced a nity for the substrate (Verma et al., 2012).
In some cases immobilization of the same enzyme on di↵erent supports showed
contrasting e↵ects. A. niger  -galactosidase was completely inactivated when
bound to Eupergit C (epoxy-polyacylamide) (Mateo et al., 2000) but retained
more activity in epoxy-Sepabeads (polystyrene-polyvinylbenzene) showing that
there is no fixed relationship between the funcional group and the enzyme, and
other factors such as the composition of the support may influence the be-
haviour of immobilized enzyme. In the case of TmLac, initial activity of the
enzyme bound to epoxy-PVA was increased between 1.4-2.8 fold compared to
that of the free form, with pNP- -Gal or lactose as substrates (Figure 4.5).
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In contrast, binding to epoxy-polystyrene (Dynabeads) did not change TmLac
activity (not shown). Despite of the increased initial activity of the enzyme
bound to epoxy-PVA supports, the kinetic behaviour was similar to the free
enzyme during long-term incubations (Figure 4.13). This could be explained
by di↵erences in product inhibition or by an ine cient agitation system. The
transglycosylation e ciency of the enzyme was not altered either upon covalent
binding (Figure 4.21).
Enzyme stabilization upon covalent immobilization has been extensively re-
ported (Mateo et al., 2000; Cowan and Fernandez-Lafuente, 2011). Multipoint
attachment due to covalent immobilization rigidifies the structure and con-
tributes to stabilize a particular conformation. In the case of TmLac, after
SDS treatment of the immobilized enzyme, 60% of the bound enzyme was re-
leased (Figure 4.4). Since, according to crystallographic data (Figure 4.19)
TmLac shows an octameric structure, this result would be in agreement with
an average of 4.8 monomers (= 0.6 · 8) per holoenzyme not covalently attached
to the support. Consequently TmLac is covalently attached through at least
3.2 linkages per holoenzyme. This may be explain the higher stability shown
by the bound enzyme at low temperatures (Figure 4.6). The fact that the sta-
bility of the soluble TmLac at low temperatures is mainly compromised when
the enzyme is diluted may reflect an unstabilization of the oligomeric struc-
ture in these conditions. This may be explained if hydrophobic interactions,
which are weaker at low temperatures, make a significant contribution to the
inter-subunit surfaces.
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Figure 5.1: Domain architectures of the enzymes containing the CBMs used in the current
study. Asterisks mark the specific CBMs used in this work.
5.1.2 CBM-mediated non-covalent immobilization
Cellulose and chitin are the most abundant natural biopolymers and
therefore they are attractive candidates to be used as enzyme immobilization
supports. Protein adsorption through specific a nity interactions is an
interesting strategy to achieve purification and immobilization in a single step.
In this study we have analyzed CBMs from four di↵erent families to test their
binding a nity and specificity to cellulose or chitin, and the thermostability
of the hybrids generated by fusion with TmLac. The selected CBMs belong to
enzymes with xylanase or chitinase activities (Figure 5.1). However, in nature,
these CBMs are also associated to other activities in some cases, as shown
in Table 5.1. CBM9 is found in xylanases, ↵-amylases and in a few number
of cellulases. CBM2 is spread among xylanases, chitinases and cellulases. In
contrast, CBM5 and CBM19 have been found associated to chitinases only.
CBM5 and CBM2 selected for this study correspond to the CBMs of
the Chitinase A (ChiA) and Chitinase B (ChiB) from Pyrococcus furiosus,
respectively. They are located in two continuous ORFs but, the presence of
a STOP codon in the catalytic domain of ChiA yields a truncated, inactive
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Table 5.1: Activities associated to the CBMs used in this work. a The number of UniProt
entries containing each combination of catalytic module and CBM is indicated in brackets.
Domain family Associated activities a
CBM9 Uncharacterized proteins [2.153], GH10-like (xylanases)[171], his-
tidin kinase [95], GH57 (↵-amylase) [58] , GH (Glycosyl Hydro-
lases uncharacterized) [52], GH13 (↵-amylase) [43], GH97 (glu-
coamylase, ↵-glucosidase) [35], ↵/  hydrolase fold (esterase) [18],
GH5 (cellulase) [8]
CBM2 Uncharacterized proteins [793], GH18 (chitinases) [618], GH5
(cellulase, mananase, xylanase) [583], six hairpin glycosidase
(cellobiosidase/endoglucanase) [331], concavalin lectin/glucanase
A (xylanase) [199], GH10 (xylanase) [190], ↵/  hydrolase fold
(esterases related with polysaccharide hydrolysis) [165], RlpA-
like (glicosyltransferase) [75], SGNH hydrolase/esterase domain
[85], GH (Glycosyl Hydrolases uncharacterized) [43], GH2 ( -
glycosidase) [17]
CBM5 GH18 (chitinases) [1.765], chitin binding proteins [984], unchar-
acterized proteins [881], GH19 (chitinases) [530], peptidase [346],
GH (Glycosyl Hydrolases uncharacterized) [295]
CBM19 Uncharacterized proteins [28], GH18 (chitinases) [163], GH (Gly-
cosyl Hydrolases uncharacterized) [4]
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chitinase. Still, CBM5 in this protein shows a nity for chitin (Mine et al.,
2014). Interestingly, even though this CBM5 is mostly associated to chitinases
(Table 5.1) a non thermophilic CBM5 from Bacillus circulans has been used to
drive a nity purification to both, cellulose or chitin (Chong et al., 1997; Hong
et al., 2008). Hybrid TmLac CBM5 did not show a significant a nity for
chitin or cellulose under our experimental conditions. This may be an intrinsic
property of this particular CBM but we cannot rule out that the interaction
with TmLac somehow hinders polysaccharide binding.
The hybrid of TmLac with CBM19 from S.cerevisiae Cts1 chitinase was
discarded because of its low thermostability. Although this CBM derives from
a mesophilic microorganism, we wanted to test if its stability was increased
within the hybrid. However, heating at 80oC caused a massive precipitation
of the hybrid protein, probably triggered by the denaturation of the C-
terminal CBM19. Nonetheless, hybrids with CBM19 may be useful for the
immobilization of mesophilic enzymes. Indeed, the TmLac CBM19 fusion
showed some a nity for chitin at pH 8.5, although binding to cellulose was
less e cient.
Hybrids constructed using either CBM2 or CBM9 showed similar a nity
for cellulose but only CBM2 was able to bind chitin (Figure 4.10). This
broader binding specificity of CBM2 is suggested by the natural occurrence of
this module, which is associated to chitinases, cellulases and xylanases (Table
5.1). Although CBM9 association to cellulases is not very frequent (Table
5.1) the ability of this CBM to bind cellulose, as well as xylan, has been
previously shown (Boraston et al., 2001). Moreover, carbohydrate binding
modules belonging to the family 9 have been used to create new hybrid proteins
with di↵erent applications. The fusion of the CBM9 from Thermotoga maritima
Xyn10A to Clostridium thermocellum cellodextrin phosphorylase (CtCDP)
111
CHAPTER 5. DISCUSSION
resulted in a enhanced specific activity of the enzyme towards cellulose (Ye
et al., 2011). CBM9-tagging was also used to purify proteins by cellulose a nity
chromatography (Kavoosi et al., 2007) or to immobilize antibodies to cellulose
filters for pathogen biosensing (Hussack et al., 2009).
The di↵erences in polysaccharide specificity of CBM9 and CBM2 are
explained by the structural di↵erences in the binding site of these CBMs (Figure
5.2). CBM2 is classified as a type A CBM, characterized by a planar interaction
surface with carbohydrates. Linearly arranged aromatic residues (W274, W308
and W326) act as the binding platform of polysaccharides (Nakamura et al.,
2008). Previous studies suggest that E279 may form a negatively charged
patch responsible for a higher substrate specificity for chitin compared to that
for cellulose (Nakamura et al., 2008; Hanazono et al., 2016). In this study we
have observed that CBM2 a nity for cellulose increases at pH 6.5 compared to
pH 8.5 (Figure 4.10). Interestingly, among protonable residues in CBM2, only
E279 shows a predicted pKa with the pH range 6-9 (Table 5.2). This suggests
that the negative charge of this residue at pH 8.5 may interfere with cellulose
binding. Since carboxyl groups are generated during cellulose isolation and
purification (Hirosawa et al., 2001) a possible explanation for the lower a nity
of TmLac CBM2 at pH 8.5 may be the electrostatic repulsion between E279
and the negative charge of cellulose fibres. Apart from its pH dependence,
the planar architecture of the CBM2 binding site seems suitable to interact
with both cellulose or chitin. In contrast, type C CBM9 seems to be more
substrate restrictive (Figure 5.2 B). The pocket-shaped binding site allows the
interaction with two consecutive moieties of the polysaccharide, being more
adapted to bind terminal ends. As show in the Figure 5.2 B a cellobiose
molecule is attached to the CBM9 through two confronting aromatic residues,
W71 andW175, interacting with opposite faces of the disaccharide (Notenboom
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Figure 5.2: Binding surface of CBM2 and CBM9. A CBM2 structure from Pyrococcus
furiosus (PDB 2CWR) with a cellulose fragment (green) docked manually. B Thermotoga
maritima CBM9 structure from xylanase 10A in complex with cellobiose (green) (PDB
1I82). Aromatic residues are coloured in orange. Residues forming polar contacts with
the corresponding substrates are coloured in blue.
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Table 5.2: CBM2 and CBM9 residues with predicted pKa values between 6-9 calculated by
PROPKA (Olsson et al., 2011).
Residue pKa Structural location
CBM2 E279 6.0 Strand
CBM9 H85 7.3 Loop (Calcium binding site 1)
E130 6.0 Strand (Calcium binding site 1)
E26 6.6 Loop
D74 8.7 Strand (Calcium binding site 2)
D94 6.6 Strand (Calcium binding site 3)
et al., 2001). Additionally, a network of polar contacts involving multiple
residues (E77, Q96, R98, Q151, R161, N172) further stabilizes binding and
may explain the high specificity for cellulose as substrate vs. chitin observed
in TmLac CBM9. Indeed, the N-acetyl-glucosamine substitution present in
chitin would preclude binding by imposing sterical impediments. In this case,
pH dependence is also observed for cellulose binding (Figure 4.10). This may
be also a result of protonation/deprotonation of critical residues in the binding
site (e.g. E77, R98, R161) although the predicted pKa of these residues is out
of the pH range 6-9. Alternatively, conformational changes at the binding site
may arise from long-distance e↵ects. Indeed, four residues with predicted pKa
between 6 and 9 are involved in three di↵erent calcium binding sites (Table
5.2), with a stabilizing role (Notenboom et al., 2001).
The di↵erent behaviour of TmLac CBM9 and TmLac CBM2 in response
to glucose and galactose addition regarding cellulose binding (Figure 4.11)
may be explained as well by the architecture of their corresponding binding
sites. Contact between the carbohydrate polymers and CBM2 occurs by ⇡-
C-H interactions between three linearly arranged tryptophan residues and
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a polysaccharide stretch, involving at least five moieties (Figure 5.2 A),
suggesting a low binding a nity for monosaccharides. In contrast, the small
pocket-shaped binding site of the CBM9, with the two tryptophan residues
arranged at opposite faces of substrate and including multiple polar contacts,
makes the competition of glucose or galactose more likely, releasing the enzyme
from the cellulose support.
Hybrid TmLac CBM2 retained 100% of activity after binding to cellulose
or chitin. However, reutilization assays for lactose hydrolysis in serial batches
showed a significant decay of the activity after 7 hours of incubation (Figure
4.14). Further experiments are required to test whether this activity loss
is due to enzyme inactivation or enzyme release from the support. In the
latter case, immobilization may be further stabilized by covalent crosslinking.
TmLac CBM2 showed the best performance among the CBMs tested, with high
thermal stability. The CBM2 module seems to be a promising tag to drive
protein immobilization. CBM2 was able to bind both cellulose and chitin,
providing a higher versatility. Moreover, binding to the support was firm,
compared to that of CBM9. Possible applications include enzyme packing
in a column to be used as continuous-flow systems (Rodriguez et al., 2004;
Velikodvorskaya et al., 2010; Tsukimoto et al., 2010).
5.2 In silico structural analysis and mutant
design
Increased GOS yield by genetic manipulation of  -galactosidases has been
reported for  -glycosidases belonging to GH1 and GH42 families but not for
GH2 enzymes. In the reported cases, mutations yielding successful results
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were located within the -1 or +1 catalytic subsites (Placier et al., 2009; Wu
et al., 2013). In this study, rational design of TmLac mutants was based
on sequence similarity and docking analysis of a structural model with  -3’-
galactosyl-lactose, the major GOS produced by TmLac (See section 4.6.1).
This complex was assumed to mimic the structure of the transgalactosylating
reaction intermediate, where the galactosyl moiety is covalently bound to E441
and a molecule of lactose is in the active site acting as acceptor of this group.
Mutations were addressed to putative subsites -1 (N574), +1/+2 (F571, W959,
D568) and +3 (V93, V94) (see Figure 4.22).
Mutations carried out at the -1 subsite, which may disrupt the hydrogen
bond with the galactosyl moiety (N574S and N574A) reduced significantly
the global activity of the enzyme (Table 4.2). However the transglycosylation
capacity was increased between 30% and 40% with a specific increment of  -
3’-galactosyl-lactose production (Figure 4.25 A). Disruption of the hydrogen
bond may decrease the a nity of the enzyme for lactose in the first stage of
the reaction, explaining the decrease of the global activity. On the other hand,
the galactosyl moiety in the covalent intermediate may have higher rotational
freedom in the mutant enzyme, favouring its transfer to the lactose molecule
acting as acceptor in the second step of the reaction. Our results also suggest
that this higher flexibility would specifically facilitate coupling to the acceptor
through a  -(1,3) linkage. Mutation N574D did not cause any significant change
in global activity (Table 4.2), enzyme accumulation (Figure 4.23) or GOS
synthesis (Figure 4.25 A). This is in agreement with the structural analysis
that predicts that the substitution of an amide group by a carboxy group
with the same side chain length still allows the formation of a hydrogen bond
with the galactosyl moiety (Figure 5.3). Our study also suggests that sequence
divergence between Asn/Asp residues observed at this position among di↵erent
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Figure 5.3: Structural detail of putative subsite -1.  -3’-galactosyl-lactose is depicted with
the galactosyl moiety at the non-reducing end in light brown, and the lactosyl group acting
as acceptor coloured in violet. Residues interacting with the galactosyl moiety at the non-
reducing end are coloured in green. Residues substituting N574 in the N574D and N574S
are overlapped and depicted in blue and orange, respectively. Dashed lines indicate putative
hydrogen bonds at this specific position.
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 -galactosidases is not associated to any functional adaptation.
According to docking studies, residues F571 and W959 conform the aromatic
binding platform for the lactose molecule acting as galactosyl acceptor (Figure
4.22). In agreement with this, substitutions of residue W959 by non-aromatic
residues resulted in a significant negative impact in transglycosylation (Figure
4.26 B). The homologous residue in E.coli galactosidase (W999) has been
assigned a double role in the catalysis of the enzyme: binding lactose in
the so-called “shallow” mode, and binding glucose in the galactosyl covalent
intermediate during allolactose synthesis (Huber et al., 2003; Wheatley et al.,
2013; Jacobson et al., 1994). Our current work suggests that this residue is
also involved in lactose binding when the molecule acts as an acceptor during
transgalactosylation. The e↵ect of W959 substitutions was specially remarkable
in the synthesis of  -3’-galactosyl-lactose (Figure 4.26 B). The  -(1,3) to  -(1,6)
ratio decreased from 2.6 in the wild-type TmLac to 1 and 0.7 in W9859C and
W959A, respectively. Interestingly,  -galactosidase from K. lactis with a Cys
residue in the homologous position synthetizes preferentially  -6’-galactosyl-
lactose (Rodriguez-Colinas et al., 2011) suggesting that this residue may be
critical for product specificity.
Substitution of highly conserved F571 by a non-aromatic residue (F571L),
resulted in a significant increase in the synthesis of  -3’-galactosyl-lactose
(Figure 4.25 B). Modelling studies suggest that this substitution may allow the
rotation of the residue W959, which is not possible in the wild-type enzyme
by steric impediment (Figure 5.4). The reorientation of this residue, may yield
a better approach of the acceptor lactose to synthesize  -3’-galactosyl-lactose.
The combination of single mutations yielding highest GOS yield (F571L/N574A
and F571L/N574S) further increased the transgalactosylating e ciency, up
to two-fold compared with the wild-type TmLac. Additive e↵ect of the two
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Figure 5.4: Structural model of wild-type TmLac and F571L mutant.  -3’-galactosyl-lactose
is depicted with the galactosyl moiety at the non reducing end in light brown, and the lactosyl
group acting as acceptor coloured in violet. The position of W959 and F571 in the wild-type
enzyme is shown in green. The structure of the F571L mutant (orange) is overlapped and
shows that the side chain of W959 is not sterically impeded to rotate to a di↵erent position.
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single mutations would produce higher flexibility of the galactosyl moiety in
the covalent intermediate and a more favorable docking of the acceptor lactose
due to the W959 reorientation. This may result in a better coupling of the
two reacting molecules. Since both N574 and F571 are highly conserved
among  -galactosidases of the GH2 family (Figure 4.22), these results may
be extrapolated to other enzymes, including those with di↵erent product
specificity. Equivalent mutations may increase the yield of di↵erent GOS
products.
5.2.1 Analysis of domain architecture and phylogenet-
ics of GH2  -glycosidases
Analysis of GH2 domain architectures (DAs) was carried out using Pfam
and Interpro databases. Proteins have been classified in 5 DA types (Figure
4.27) according to C-terminal variable topologies. TmLac is included in type
3, representing canonical  -galactosidases, except for an additional terminal
domain downstream Bgal Small N (Figure 4.15). The three-dimensional
structure of several enzymes of DA types 1 and 3 is known, such as the  -
glucuronidases from E. coli, C. perfringens or H. sapiens (Jain et al., 1996;
Wallace et al., 2010, 2015), or the  -galactosidases from Arthrobacter sp., E.
coli or K. lactis (Jacobson et al., 1994; Juers et al., 2001; Skalova et al., 2005;
Pereira-Rodriguez et al., 2012), as well as part of the structures of the  -
galactosidases from B. circulans (Ishikawa et al., 2015) and S. pneumoniae
(Cheng et al., 2012) (DA type 5). These structures reveal that GH2C interacts
with domains GH2N and with either Bgal Small N in DA type 3 proteins
or BIG1 in DA type 5, through loops that shape the catalytic site. In the
case of TmLac, W959, which has been involved in binding lactose both as
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donor and acceptor of the galactosyl moiety, resides in the Bgal Small N. The
close resemblance of Bgal Small N domains in monocistronic (DA type 3) and
bicistronic (DA type 2) proteins indicates that these two types evolved from
a common ancestor, either by gene fusion of LacL/LacM modules or by gene
disruption from the canonical type. Phylogenetic analysis of GH2C domains
(Figure 4.29) shows that bicistronic proteins emerge from branches of DA
type 3, suggesting that they evolved from monocistronic sequences by gene
disruption. The fact that bicistronic enzymes are dispersed in three di↵erent
nodes may indicate that this was not a single evolutionary event. This gene
disruption allowed the loss of the linker domain (primitive DUF4981).
Results shown in Figure 4.29 support the idea that the C-terminal domains
directed evolutionary diversification of GH2  -galactosidases. The signature
of DA type 5* proteins, whose node is represented in Figure 4.30, is the
presence of a BIG1 domain whereas the signature of the canonical DA type
3  -galactosidases is the Bgal Small N domain. Indeed, the DA type 3 cluster
includes not only canonical and bicistronic galactosidases but also a subset from
type 4 carrying a C-terminal domain of around 400 amino acids (Ct 8 3) which
is also related to Bgal Small N. This is in agreement with a close structural
relationship between the C-terminal domain and the active site within the
GH2C domain, that has been maintained through evolution. In contrast,
 -glucuronidases (DA type 1) lacking C-terminal domains are dispersed in
di↵erent nodes.
We propose a model for the evolution of the di↵erent  -galactosidases DAs
in family GH2, based on the results of sequence alignment and phylogenetic
analysis, which is presented in Figure 5.5.
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Primitive GH2 enzymes probably had the architecture GH2N+GH2+GH2C
from which current glucuronidases derive (DA type 1). Subsequently, one or
more C-terminal domains were added by gene fusion rendering types 3, 4 and
5. A group of type 3  -galactosidases gave rise to bicistronic  -galactosidases
by gene disruption. Likely, the addition of some of these C-terminal domains
such as BIG1 or Bgal Small N gave shape to the active site and determined
the specialization of GH2 enzymes in the hydrolysis of di↵erent galactosides.
In other cases, C-terminal domains seem to confer cell adhesion properties.
For example, a module (CBM71) of the  -galactosidase from Streptococcus
pneumoniae has been shown to be involved in host-pathogen recognition (Singh
et al., 2014).
This study provides new insights that will help to screen and select novel
 -galactosidases suited for specific GOS synthesis. Whereas  -(1,3) and  -
(1,6) GOS are the main products of widely characterized  -galactosidases
(classified in types 2 and 3),  -(1,4) GOS production has been described for
the B. circulans  -galactosidase (type 5) (Torres et al., 2010). This suggests
that the divergent domain architecture of  -galactosidases may be related to
the di↵erent product specificities of the transglycosylation reaction. Sequence
alignment of residues potentially involved in the catalytic site of B. circulans  -
galactosidase suggests that other DA type 5 enzymes containing a BIG1 domain
may be good candidates for  -(1,4) GOS production, despite high divergence in
C-terminal DA. Our analysis also shows the existence of a heterogeneous, poorly
characterized group of proteins (DA type 4) with divergent GH2C sequences.
Biochemical characterization of enzymes from this group may be reveal novel
properties of industrial interest.
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The results obtained in this doctoral thesis are summarized in the following
conclusions:
1. Recombinant  -galactosidase from Thermotoga maritima (TmLac) pro-
duced in E. coli, has been purified and immobilized on a epoxy-activated
polyvinyl alcohol resin. The resulting covalent, multi-point attachment
of the protein to the support improves the enzyme stability and allows
its use for lactose hydrolysis in repeated batches.
2. Hybrid enzymes composed of Thermotoga maritima  -galactosidase fused
to diverse carbohydrate binding modules, have been constructed. The
best results were achieved with a hybrid containing a CBM2 from
Pyrococcus furiosus chitinase A. The hybrid is thermostable and can be
attached under controlled conditions to cellulose and chitin.
3. With lactose as the substrate, TmLac carries out transglycosylation
of a galactosyl residue to a lactose acceptor molecule, giving rise to
two di↵erent trisaccharides:  -3’-galactosyl-lactose and  -6’-galactosyl-
lactose at a 3:1 molar ratio.
4.  -3’-Galactosyl-lactose synthesis has been improved up to 40% by
mutating the Asp 574 from TmLac structure to Ser or Ala. The observed
e↵ect may be due to increased rotational freedom of the galactosyl residue
being transferred to the acceptor lactose.
5. The Trp at position 959 in the TmLac structure is actively involved in
transglycosylation. Substitution of W959 by non-aromatic residues (such
as Cys or Ala) decreases  -3’-galactosyl-lactose by about 80%, whereas
change to another aromatic residue (Phe) does not cause any e↵ect. We
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suggest that this aromatic residue acts as a binding platform for the
lactose molecule acting as galactosyl acceptor.
6. Change of Phe at position 571 to Leu increases  -3’-galactosyl-lactose
synthesis by about 40%. This mutation may modify the orientation of
the lactose binding platform to a more favourable position.
7. Several of the isolated mutations that increase the tranglycosylating
activity of TmLac have an additive e↵ect. So far a 2-fold increase of
the transglycosylating activity of the wild-type has been achieved with
mutants F571L/N574A and F571L/N574S.
8. Protein sequences from glycosyl hydrolases family 2, to which TmLac
belongs, have been classified in five types, based on their domain
architecture. Proteins of the family show a conserved structure at the
N-terminal region of their sequence, but have a high versatility at the
C-terminal region.
9. Phylogenetic analysis shows a close relationship between the evolution
of the GH2C catalytic domain and the presence of specific C-terminal
modules. A model has been proposed to explain the evolution of the
di↵erent domain architectures existing in the family.
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A. Functions developed in PYTHON
To obtain the data used in the DA study of the GH2 family di↵erent
functions were created using PYTHON language that allowed to obtain the
necessary data for the analysis performed in the current work. In this
section the di↵erent functions that compose the script “Domain study.py” are
described. Note that this code is for particular input files and with a particular
data format, because of that it may not work for other files without previous
editing.
Domain seq function
Domain seq function prints the sequence between two coordinates defined
by Pfam domain coverage using as reference the Pfam envelope coordinates.
def domain_seq(sequence , coordinate):
start=int(coordinate [0]) -1
endd = int(coordinate [1])
seq = sequence[start:endd]
if not seq.strip():
print ’sequence is empty ’, coordinate , start , endd
return seq
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Get sequence dict function
This function creates a dictionary using the Gene Bank numbers (GI) as
keys and the protein sequences as values from FASTA sequences file, indicated
as “Sequences.txt’ on the code.
def get_sequece_dict ():
f2=open(’Sequences.txt’, ’r’)
fasta=f2.read()
f2.close ()
fasta_dic ={}
entry=fasta.split(">")[1:]
for line in entry:
sp=line.split(’\n’ ,1)
sp1=sp[0]
sp2=sp[1]. replace("\n", "")
fasta_dic[sp1]=sp2
return fasta_dic
Create domaindict function
This function creates the dictionary domaindict using the GI numbers as
keys and a list of Pfam domain names as values. It also, creates the do-
maindict2 dictionary which contains the GI numbers as keys and the list of
coordinates for all the Pfam domains belonging to GI from the Uniprot file as
values, showed in the code as “UNIPROT INFO.txt”.
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def create_domaindict ():
f = open(’UNIPROT_INFO.txt’, ’r’)
domaindict=dict()
domaindict2=dict()
for line in f:
l = re.split(’/’, line)
if l[0] not in domaindict:
li=[]
li.append(l[5])
domaindict[l[0]]=li
else:
li=domaindict[l[0]]
li.append(l[5])
domaindict[l[0]]=li
list1=[l[3],l[4]]
if l[0] not in domaindict2:
li2 =[]
li2.append(list1)
domaindict2[l[0]]= li2
else:
li2=domaindict2[l[0]]
li2.append(list1)
domaindict2[l[0]]= li2
f.close()
return domaindict , domaindict2
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Create binary colnames function
This function creates a dictionary using the GI as keys and the binary vector
as value, where each value corresponds to the presence/absence to each Pfam
domain.
def create_binary_colnames(domaindict):
pfam_list =[]
coutunters ={}
for domains in domaindict.values ():
cc=Counter(domains)
for i in cc:
if i not in coutunters.keys():
coutunters[i]=[]
coutunters[i]. append(cc[i])
pfam_list.extend(domains)
pfam_list=list(set(pfam_list))
print pfam_list
kk=coutunters.keys()
kk.sort()
col_names =[]
for i in kk:
for j in range(1, max(coutunters[i]) +1):
col_names.append(i + ’_’ + str(j))
print ’\n’.join(col_names)
print len(col_names)
return col_names
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Print functions
These functions were created to print and parse the data in a correct format.
def print_bin(gi , t):
a = gi.split(’|’)[1]
print a, ’ ’*(10-len(a)), parse_vec(t),
def parse_vec(t):
return ’’.join([str(i) for i in t])
Create tree dict function
This function creates a diccionary using GI numbers as keys and binary
vectors as values. Data obtanied from this script prints the GI, binary vector
and the Pfam domain codes which correspond to the domain composition.
def create_tree_dict(domaindict , col_names):
tree_dict ={}
for gi in domaindict.keys():
t=[0]* len(col_names)
dd=domaindict[gi]
cc=Counter(dd)
for pf in cc:
for j in range(1, cc[pf]+1):
counted_pf = pf + ’_’ + str(j)
t[col_names.index(counted_pf)]=1
tree_dict[gi]=tuple(t)
print_bin(gi , t)
print " ".join(domaindict[gi])
return tree_dict
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Create binary unique function
This function creates a dictionary using the binary vector as keys and a list
of all the GI numbers with the same vector as values.
def create_binary_unique(tree_dict , col_names):
done ={}
for gi in tree_dict:
if tree_dict[gi] not in done:
done[tree_dict[gi ]]=[]
done[tree_dict[gi]]. append(gi)
return done
Stats function
This function allows to calculates the distribution of each domain archi-
tecture reporting the binary vector and the GI number that have the same
composition.
def stats(tree_dict):
cc=Counter(tree_dict.values ())
kk=cc.keys()
kk.sort()
for k in kk:
print cc[k],’;’, parse_vec(k)
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Get sequence for domain from all function
This function allows to obtain the sequence for a particular Pfam domain
indicated on the main function introducing the Pfam number.
def get_sequence_for_domain_from_all(domaindict , domaindict2 ,
fasta_dic , binaryToGis , domainName):
OUT ={}
for vec in binaryToGis.keys():
print "\n" , parse_vec(vec)
for gi in binaryToGis[vec]:
for name , pos in zip(domaindict[gi],
domaindict2[gi]):
if name== domainName:
pos=[int(i) for i in pos]
seq=domain_seq(fasta_dic[
gi], pos)
print ">" + gi + "\n" +
seq
return OUT
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Main function
The main function allows to coordinate the above functions and modify
certain parameters in order to obtain specific data. In this function the Pfam
number of the domain is used to obtain their sequence.
def main():
domaindict , domaindict2=create_domaindict ()
col_names=create_binary_colnames(domaindict)
tree_dict=create_tree_dict(domaindict , col_names)
binaryToGis=create_binary_unique(tree_dict , col_names)
fasta_dic=get_sequece_dict ()
get_sequence_for_domain_from_all(domaindict , domaindict2 ,
fasta_dic , binaryToGis , "PFAMnumber")
stats(tree_dict)
main()
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B. Chemical structure of amino acids
163

Appendix
C. Acronyms and abreviatures
CAZy: Carbohydrate-Active EnZymes.
CE: Cellulose
CBM: Carbohydrate Binding Module.
CH: Chitin.
CLEAs Cross-linked enzymes aggregates.
CLECs Cross-linked enzymes crystals.
CMP Cytidine 5’-Monophosphate.
Ctx: Cholera toxin.
DA: Domain Architecture.
EC: Enzyme Commission.
EcLac: E. coli  -galactosidase.
FOS: Fructooligosaccharide.
Gal: Galactose.
GDP Guanidine 5’-Diphosphate.
GH: Glycosyl hydrolase.
GI: Gene Identifier.
Glc: Glucose.
GOS: Galactooligosaccharides.
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GTP Guanidine 5’-Triphosphate.
IPTG: Isopropyl  -D-1-thiogalactopyranoside
kDa: kiloDalton.
LNP: Lactase non-persistant.
LP: Lactase persistant.
OD: Optical Density.
PCR: Polymerase chain reaction.
pNP- -Gal: p-nitrophenyl  -D-Galactopyranoside.
SDS-PAGE: Sodium Dodecyl Sulfate PolyAcrylamide Gel Electrophoresis.
SCFA: Short Chain Fatty Acid.
TmLac: Thermotoga maritima  -galactosidase
UDP: Uridine 5’-Diphosphate.
WT: Wild Type.
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